<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32117416</article-id>
<article-id pub-id-type="pmc">7016268</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.01365</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Genetics and Epigenetics of 22q11.2 Deletion Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Qiumei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/777702" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de la Morena</surname>
<given-names>M. Teresa</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Oers</surname>
<given-names>Nicolai S. C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/775483" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Immunology, The University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pediatrics, The University of Washington and Seattle Children’s Hospital</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Dan Koboldt, Nationwide Children’s Hospital, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marita Bosticardo, National Institute of Allergy and Infectious Diseases, United States; Thomas M Maynard, George Washington University, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Nicolai S. C. van Oers, <email xlink:href="mailto:Nicolai.vanoers@utsouthwestern.edu" xlink:type="simple">Nicolai.vanoers@utsouthwestern.edu</email>
</corresp>
<fn fn-type="present-address" id="fn002">
<p>†Present address: Qiumei Du, Harbor Biomed MA, United States</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Genetic Disorders, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>1365</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Du, de la Morena and van Oers</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Du, de la Morena and van Oers</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Chromosome 22q11.2 deletion syndrome (22q11.2del) is a complex, multi-organ disorder noted for its varying severity and penetrance among those affected. The clinical problems comprise congenital malformations; cardiac problems including outflow tract defects, hypoplasia of the thymus, hypoparathyroidism, and/or dysmorphic facial features. Additional clinical issues that can appear over time are autoimmunity, renal insufficiency, developmental delay, malignancy and neurological manifestations such as schizophrenia. The majority of individuals with 22q11.2del have a 3 Mb deletion of DNA on chromosome 22, leading to a haploinsufficiency of ~106 genes, which comprise coding RNAs, noncoding RNAs, and pseudogenes. The consequent haploinsufficiency of many of the coding genes are well described, including the key roles of <italic>T-box Transcription Factor 1</italic> (<italic>TBX1</italic>) and <italic>DiGeorge Critical Region 8</italic> (<italic>DGCR8</italic>) in the clinical phenotypes. However, the haploinsufficiency of these genes alone cannot account for the tremendous variation in the severity and penetrance of the clinical complications among those affected. Recent RNA and DNA sequencing approaches are uncovering novel genetic and epigenetic differences among 22q11.2del patients that can influence disease severity. In this review, the role of coding and non-coding genes, including microRNAs (miRNA) and long noncoding RNAs (lncRNAs), will be discussed in relation to their bearing on 22q11.2del with an emphasis on <italic>TBX1</italic>.</p>
</abstract>
<kwd-group>
<kwd>22q11.2 deletion syndrome</kwd>
<kwd>DiGeorge syndrome</kwd>
<kwd>
<italic>TBX1</italic>
</kwd>
<kwd>noncoding RNAs</kwd>
<kwd>microRNAs</kwd>
<kwd>epigenetics</kwd>
<kwd>haploinsufficiency</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn001">R01 AI114523</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="173"></ref-count>
<page-count count="16"></page-count>
<word-count count="8087"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Genetics of 22q11.2 Deletion Syndrome</title>
<p>Chromosome 22q11.2 deletion syndrome (22q11.2del) (OMIM #’s 188400, 192430, 611867) is the most common chromosomal microdeletion reported in humans, affecting ~1/4,000 individuals (<xref ref-type="bibr" rid="B16">Botto et al., 2003</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B43">Fung et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>). Screening fetuses for 22q11.2del by prenatal procedures reveals an even higher frequency of ~1/1,000, suggesting a high morbidity <italic>in utero</italic> (<xref ref-type="bibr" rid="B156">Wapner et al., 2012</xref>; <xref ref-type="bibr" rid="B47">Grati et al., 2015</xref>). The disease is multi-syndromic of contrasting severity and penetrance among those affected. It can include congenital heart disease (CHD; especially conotruncal malformations, tetralogy of Fallot, aortic arch abnormalities, truncus arteriosus, ventricular septal defects and vascular rings) and abnormalities of the palate (clefts and velopharyngeal incompetence) (<xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B43">Fung et al., 2015</xref>; <xref ref-type="bibr" rid="B50">Guna et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B96">Meechan et al., 2015</xref>; <xref ref-type="bibr" rid="B107">Morsheimer et al., 2017</xref>; <xref ref-type="bibr" rid="B145">Sullivan, 2019</xref>). Hypoplasia of the thymus, hypoparathyroidism, dysmorphic facial features, renal and/or skeletal anomalies are also common (<xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B145">Sullivan, 2019</xref>). Those in whom an immune deficiency is identified are often classed as having DiGeorge syndrome (<xref ref-type="bibr" rid="B28">Conley et al., 1979</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B90">Markert et al., 2007</xref>; <xref ref-type="bibr" rid="B89">Marcovecchio et al., 2019</xref>). DiGeorge syndrome is first suggested following newborn screens for detecting the levels T-cell receptor excision circles (TRECs) as a measure of T cell output from the thymus (<xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref>) (<xref ref-type="bibr" rid="B16">Botto et al., 2003</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>). Low TRECs can be an indicator of DiGeorge syndrome, with the diagnosis of 22q11.2del subsequently established by FISH or chromosomal microarray technologies (<xref ref-type="bibr" rid="B70">Kwan et al., 2014</xref>; <xref ref-type="bibr" rid="B151">Van Der Spek et al., 2015</xref>; <xref ref-type="bibr" rid="B130">Schmid et al., 2017</xref>; <xref ref-type="bibr" rid="B119">Ravi et al., 2018</xref>). The heterogeneous congenital problems for 22q11.2del patients arise from defective remodeling of the pharyngeal region during embryogenesis (<xref ref-type="bibr" rid="B144">Sullivan, 2004</xref>; <xref ref-type="bibr" rid="B7">Bassett et al., 2005</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B43">Fung et al., 2015</xref>; <xref ref-type="bibr" rid="B50">Guna et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B4">Baldini et al., 2016</xref>). Impacted is the second heart field and the pharyngeal arch arteries, which form the outgrowth vessels of the heart, as well as the pharyngeal pouches (PP), with the 3<sup>rd</sup> PP forming the thymic lobes and inferior parathyroids (<xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B158">Xu et al., 2004</xref>; <xref ref-type="bibr" rid="B22">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B1">Alfano et al., 2019</xref>). Over time, individuals with 22q11.2del often exhibit developmental delay and autoimmune manifestations, with their malignancy risk higher compared to the general population. Autism and autism spectrum, anxiety, attention deficit disorders and psychiatric illnesses like schizophrenia are common (<xref ref-type="bibr" rid="B91">Mcdonald-Mcginn et al., 1999</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B61">Karayiorgou et al., 2010</xref>; <xref ref-type="bibr" rid="B107">Morsheimer et al., 2017</xref>; <xref ref-type="bibr" rid="B145">Sullivan, 2019</xref>; <xref ref-type="bibr" rid="B172">Zinkstok et al., 2019</xref>). Males and females with 22q11.2del are equally affected, regardless of their racial/ethnic grouping (<xref ref-type="bibr" rid="B112">Óskarsdóttir et al., 2005</xref>; <xref ref-type="bibr" rid="B66">Kobrynski and Sullivan, 2007</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B68">Kruszka et al., 2017</xref>). The least concordant phenotypes occur in children of African descent (<xref ref-type="bibr" rid="B68">Kruszka et al., 2017</xref>). Not surprisingly given the numerous organ systems affected, 22q11.2del patients have a diminished life expectancy (<xref ref-type="bibr" rid="B121">Repetto et al., 2014</xref>). Mid-aged 22q11.2del individuals have a median life expectancy of 42 years compared to normal sibling controls (60–70 yrs. of age) (<xref ref-type="bibr" rid="B92">Mcdonald-Mcginn et al., 2006</xref>; <xref ref-type="bibr" rid="B8">Bassett et al., 2009</xref>; <xref ref-type="bibr" rid="B9">Bassett et al., 2011</xref>; <xref ref-type="bibr" rid="B121">Repetto et al., 2014</xref>). With such a wide gamut of problems, a multi-disciplinary clinical approach is often needed to provide adequate care for children and adolescents with 22q11.2del. This can definitely improve the overall quality of life for 22q11.2del patients, which is lower than normal (<xref ref-type="bibr" rid="B43">Fung et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>). Yet, health care costs for 22q11.2del patients can reach a staggering $1,000,000 during their first 20 years of life (<xref ref-type="bibr" rid="B17">Brenner et al., 2016</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Clinical manifestations of 22q11.2 and 22q11.2-like deletion syndromes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="top"></th>
<th align="center" colspan="4" rowspan="1" valign="top">Chromosomal regions affected</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">10p14-13</td>
<td align="left" colspan="1" rowspan="1" valign="top">4q34.1-q35.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">3p10.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Frequency</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/4000</td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;100 individuals</td>
<td align="left" colspan="1" rowspan="1" valign="top">rare</td>
<td align="left" colspan="1" rowspan="1" valign="top">rare</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Length of DNA deletion</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 Mb or 1.5 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">17.4 Mb</td>
<td align="left" colspan="1" rowspan="1" valign="top">300 kb</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Clinical Phenotype</bold>
</td>
<td align="center" colspan="4" rowspan="1" valign="top">% occurrence</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Congenital heart disease (CHD)<xref ref-type="table-fn" rid="fnT1_1">
<sup>a</sup>
</xref>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">75%</td>
<td align="left" colspan="1" rowspan="1" valign="top">82%</td>
<td align="left" colspan="1" rowspan="1" valign="top">15%</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Immune deficiency (thymic hypoplasia)<xref ref-type="table-fn" rid="fnT1_2">
<sup>b</sup>
</xref>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">50–70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">17%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hypocalcemia (hypoparathyroidism)</td>
<td align="center" colspan="1" rowspan="1" valign="top">35%</td>
<td align="left" colspan="1" rowspan="1" valign="top">22%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dysmorphic craniofacial features</td>
<td align="center" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">95-99%</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Developmental delay</td>
<td align="center" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">80-90%</td>
<td align="left" colspan="1" rowspan="1" valign="top">10%</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Renal anomalies</td>
<td align="center" colspan="1" rowspan="1" valign="top">14%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Skeletal defects</td>
<td align="center" colspan="1" rowspan="1" valign="top">60%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">55%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Learning problems</td>
<td align="center" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">80-99%</td>
<td align="left" colspan="1" rowspan="1" valign="top">65%</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Psychiatric disorders<xref ref-type="table-fn" rid="fnT1_3">
<sup>c</sup>
</xref>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">30%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gastrointestinal abnormalities</td>
<td align="center" colspan="1" rowspan="1" valign="top">30%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Digital malformations (polydactyly)</td>
<td align="center" colspan="1" rowspan="1" valign="top">30%</td>
<td align="left" colspan="1" rowspan="1" valign="top">30-80%</td>
<td align="left" colspan="1" rowspan="1" valign="top">88%</td>
<td align="left" colspan="1" rowspan="1" valign="top">nr<xref ref-type="table-fn" rid="fnT1_4"><sup>d</sup></xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT1_1">
<label>a</label>
<p>CHD includes interrupted aortic arches, Tetralogy of Fallot, right subclavian artery defects, ventricular septal defects, pulmonary atresia, and other outflow tract anomalies.</p>
</fn>
<fn id="fnT1_2">
<label>b</label>
<p>Immune deficiency is defined with peripheral T cell counts less than 1500 cells/µl.</p>
</fn>
<fn id="fnT1_3">
<label>c</label>
<p>Psychiatric disorders can include autism, schizophrenia, seizure disorder.</p>
</fn>
<fn id="fnT1_4">
<label>d</label>
<p>nr, not reported.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Ninety percent of individuals with 22q11.2del have a 3 Mb microdeletion on chromosome 22, resulting in a hemizygosity of approximately 106 genes (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>) (<xref ref-type="bibr" rid="B50">Guna et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>). Forty-six of these are protein coding, 24 are pseudogenes and the remainder comprise non-coding RNAs; 7 microRNAs (miRNAs), 12 long noncoding RNAs (lncRNAs), 2 small nucleolar RNAs (snoRNAs), and additional undefined transcripts. About 5-8% of 22q11.2del individuals have a smaller, nested deletion of 1.5 Mb (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). This leads to a haploinsufficiency of 30 coding genes, as well as 6 and 9 of the miRNAs and lncRNAs affected with the longer deletion, respectively. Both types of deletions are due to erroneous chromosomal rearrangements during meiosis. These exchanges involve 8 large, paralogous low copy repeats (LCRs), or segmental duplications (A–H) that are distributed along a 5.6 Mb segment of chromosome 22q11.2 (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>) (<xref ref-type="bibr" rid="B134">Shaikh et al., 2001</xref>; <xref ref-type="bibr" rid="B55">Hwang et al., 2014</xref>). DNA recombination of the LCRs, which are 96% sequence identical, during cross-over exchanges results in erroneous deletions or duplications (<xref ref-type="bibr" rid="B133">Shaikh et al., 2000</xref>; <xref ref-type="bibr" rid="B134">Shaikh et al., 2001</xref>; <xref ref-type="bibr" rid="B15">Bittel et al., 2009</xref>). Distributed within or around the LCRs are 8 long intergenic noncoding RNAs (lncRNAs). These lncRNAs contain Translocation Breakpoint Type A (TBTA) sequences with homology to FAM230C, a lncRNA on chromosome 13 (<xref ref-type="bibr" rid="B32">Delihas, 2018</xref>). Such lncRNAs may contribute to the deletions <italic>via</italic> the translocation breakpoint sequences. The most frequent deletion in 22q11.2del patients spans LCR A-D (3 Mb), with a less frequent deletion between LCR A-B (1.5 Mb) (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). These are referred to as proximal deletions and are causal to the majority of clinical phenotypes ascribed to 22q11.2del. The actual breakpoint location within the LCR does not have a major role in 22q11.2del phenotypes (<xref ref-type="bibr" rid="B14">Bertini et al., 2017</xref>). A rare number of individuals have deletions between LCR B-D or LCR C-D, which are referred to as central deletions. These deletions can also cause CHD and/or neurological abnormalities (<xref ref-type="bibr" rid="B128">Saitta et al., 1999</xref>; <xref ref-type="bibr" rid="B19">Burnside, 2015</xref>). Even more infrequent are deletions between LCR C-E, LCR D-E, and LCR E-F, although the reported clinical phenotypes are not characteristic of 22q11.2del (<xref ref-type="bibr" rid="B128">Saitta et al., 1999</xref>; <xref ref-type="bibr" rid="B135">Shaikh et al., 2007</xref>; <xref ref-type="bibr" rid="B19">Burnside, 2015</xref>; <xref ref-type="bibr" rid="B50">Guna et al., 2015</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Genetic organization of the human chromosome 22q11.2 locus and synteny on murine chromosome 16. Human chromosome 22 is approximately 51 million base pairs. The region affected by the 22q11.2 chromosomal deletions and duplications spans approximately 4 Mb, with 8 low copy repeats (LCR A-LCR H) causal to this distributed throughout this region. LCR A-LCR D are shown. Recombination of these highly homologous sequences (also called segmental duplications) results in proximal, central, and distal (not shown) deletions affecting both coding and noncoding DNA segments. The proximal deletions are responsible for the classic clinical features of 22q11.2del, which includes DiGeorge syndrome. The location of the coding genes, and noncoding RNAs including miRNAs and lncRNAs, are shown for the proximal region of chromosome 22q11.2. The corresponding genes on the murine locus are connected with lines, which reveals a flipping of the locus and a break containing distinct genes. Three of the more commonly used mouse models of 22q11.2del that replicate many clinical features of 22q11.2del are shown, named as the Df16(A), Df1 and Lgdel lines.</p>
</caption>
<graphic xlink:href="fgene-10-01365-g001"></graphic>
</fig>
<p>The role of many of the genes whose haploinsufficiency contributes to the congenital malformations, immune system complications, neurological issues and other clinical phenotypes are well-described and discussed in many reviews (<xref ref-type="bibr" rid="B167">Zemble et al., 2010</xref>; <xref ref-type="bibr" rid="B9">Bassett et al., 2011</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B96">Meechan et al., 2015</xref>; <xref ref-type="bibr" rid="B107">Morsheimer et al., 2017</xref>; <xref ref-type="bibr" rid="B106">Morrow et al., 2018</xref>; <xref ref-type="bibr" rid="B145">Sullivan, 2019</xref>; <xref ref-type="bibr" rid="B172">Zinkstok et al., 2019</xref>). Among some of the more well-characterized genes are <italic>T-Box 1 Transcription Factor</italic> (<italic>TBX1</italic>)<italic>, DiGeorge Syndrome Critical Region 8</italic> (<italic>DGCR8</italic>), <italic>Crk-like Adaptor Protein L</italic> (<italic>CRKL</italic>), <italic>Proline Dehydrogenase</italic> (<italic>PRODH</italic>), <italic>Reticulon 4 Receptor</italic> (<italic>RTN4R</italic>), <italic>Zinc-finger DHHC-type Containing 8</italic> (<italic>ZDHHC8</italic>), <italic>Catechol-O-Methyl Transferase</italic> (<italic>COMT</italic>), <italic>Guanine Nucleotide Binding Protein b-polypeptide 1-Like</italic> (<italic>GNB1L</italic>), <italic>Septin 5</italic> (<italic>SEP5</italic>) and <italic>Glycoprotein Ib Platelet Subunit Beta</italic> (<italic>GP1BB</italic>). Yet, the haploinsufficiency of these genes is clearly unable to explain the heterogeneous penetrance and severity of clinical phenotypes that differ from patient to patient. This is even noted among family members with the same mutation in <italic>TBX1</italic> and with genetically identical in-bred strains of mice used as models of 22q11.2del syndrome. In this review, we present recent findings revealing how variations in the expression of <italic>TBX1</italic>, the functions of <italic>DGCR8</italic>, and the miRNAs and long noncoding RNAs within and outside the 22q11.2 locus can influence the severity of the clinical manifestations of 22q11.2del (<xref ref-type="table" rid="T1">
<bold>Tables 1</bold></xref>–<xref ref-type="table" rid="T3">
<bold>3</bold>
</xref>). We also review data identifying gene duplications, CNVs, SNPs, and other chromosomal abnormalities that impact 22q11.2del patients and/or result in overlapping 22q11.2-like phenotypes in some individuals.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Epigenetic modifiers of 22q11.2 locus: Noncoding RNA regulators and noncoding RNAs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1" valign="top">Type of RNA</th>
<th colspan="1" rowspan="1" valign="top">RNA transcript affected</th>
<th colspan="1" rowspan="1" valign="top">Location on 22q11.2</th>
<th colspan="1" rowspan="1" valign="top">Murine Homologs</th>
<th colspan="1" rowspan="1" valign="top">Confirmed targets<xref ref-type="table-fn" rid="fnT2_2">
<sup>b</sup>
</xref>
</th>
<th colspan="1" rowspan="1" valign="top">Tissue Expression</th>
<th colspan="1" rowspan="1" valign="top">Pathways affected<xref ref-type="table-fn" rid="fnT2_3">
<sup>c</sup>
</xref>
</th>
</tr>
</thead>
<tbody>
<tr>
<th align="left" colspan="7" rowspan="1" valign="top">Modifiers Encoded within 22q11.2del</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Coding</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DiGeorge Syndrome Critical Region 8</italic> (<italic>DGCR8</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Dgcr8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Global mRNAs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">miRNA biogenesis<break></break>Alzheimer's disease<break></break>Schizophrenia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="8" valign="top">MiRNAs (7)</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-185</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-185</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Btk, SERCA2, Camk4, NFAT3c, Mzb1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thymus, brain,<break></break>heart, T and B cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">T and B cell signaling, cardiomyocyte hypertrophy, calcium responses</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-4761<xref ref-type="table-fn" rid="fnT2_1">
<sup>a</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">none</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted: Dopamine metabolism and neurotransmitter clearance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-3618</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B<break></break>5' UTR of <italic>DGCR8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">none</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted: RNA capping<break></break>Gene expression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-1306</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B<break></break>Exon 1 of <italic>DGCR8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-1306</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FBLX5, TGF-beta receptor II</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted: mRNA capping and gene expression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-6816<xref ref-type="table-fn" rid="fnT2_1">
<sup>a</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">none</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not determined</td>
<td align="left" colspan="1" rowspan="1" valign="top">unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-1286</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Only in primates<xref ref-type="table-fn" rid="fnT2_5">
<sup>e</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cerebellum</td>
<td align="left" colspan="1" rowspan="1" valign="top">unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-649</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRD</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-649</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MALT1</italic> (NF-kB pathway)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oral mucosa,<break></break>muscle</td>
<td align="left" colspan="1" rowspan="1" valign="top">HSV infection susceptibility</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RNA transcript affected</td>
<td align="left" colspan="1" rowspan="1" valign="top">Location on 22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Highest RPKM (tissue sites)<xref ref-type="table-fn" rid="fnT2_4">
<sup>d</sup>
</xref>
</td>
<td align="left" colspan="2" rowspan="1" valign="top">Dominant Sites of Tissue Expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Function</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="12" valign="top">LncRNAs (12)</td>
<td align="left" colspan="1" rowspan="1" valign="top">DGCR5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRA</td>
<td align="left" colspan="1" rowspan="1" valign="top">40 (cerebellum, cortex)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Brain, pancreas, pituitary</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targets miR-1180, miR-23b</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DGCR9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">25 (cerebellum)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Brain, pituitary</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell proliferation and glucose uptake</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DGCR11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 (Skin)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Brain, skin, blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within DGCR2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AC004471.10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 (testes)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Brain, muscle, skin, testes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein homolog TSSK2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LINC01311</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.4 (brain, testes)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AC000067.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.1 (brain)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Arteries, brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LINC00895</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not reported</td>
<td align="left" colspan="2" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LINC00896</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.3 (thyroid, pituitary)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Pituitary, thyroid</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulated by miR-139</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">XXbac-B444P24.14<break></break>(ENSG00000273139)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRB</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.8 (pituitary, thyroid)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">XXbac-B33L19.4<break></break>(ENSG00000235578)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRB</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 (testes)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Testes</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">XXbac-B135H6.18<break></break>(ENSG00000272829)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRC-D</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 (pituitary)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Brain, muscle, pituitary</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">KB1592A4.15<break></break>(ENSG00000197210.7)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Within LCRD</td>
<td align="left" colspan="1" rowspan="1" valign="top">40 (testes)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Testes</td>
<td align="left" colspan="1" rowspan="1" valign="top">To be determined</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">SnoRNAs (2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNORA15</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.2</td>
<td align="left" colspan="2" rowspan="1" valign="top">Nucleolus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nucleolar RNA guide for modifying uridine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SNORA77</td>
<td align="left" colspan="1" rowspan="1" valign="top">Between LCRA-B</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 (brain) 7 (testes)</td>
<td align="left" colspan="2" rowspan="1" valign="top">Nucleolus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Guide for modifying uridine on 18S rRNA</td>
</tr>
<tr>
<th align="left" colspan="7" rowspan="1" valign="top">Modifiers Encoded outside the 22q11.2del locus</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Type of RNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA transcript affected</td>
<td align="left" colspan="1" rowspan="1" valign="top">Location</td>
<td align="left" colspan="1" rowspan="1" valign="top">Murine Homologs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Confirmed targets</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tissue expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pathways affected<xref ref-type="table-fn" rid="fnT2_2">
<sup>b</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MiRNAs</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-96a</td>
<td align="left" colspan="1" rowspan="1" valign="top">chr7:129774692-129774769</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-96a</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TBX1, FOXO1, FOXO3a, RECK, EphrinA5 and SAMD9</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sensory organs, inner ear, eye, nose</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cilia and hearing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-451a</td>
<td align="left" colspan="1" rowspan="1" valign="top">chr17:28861369-28861400</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-451a</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TBX1, Mif, c-myc, AKT1, SPARC</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wound healing and cellular differentiation</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT2_1">
<label>a</label>
<p>Read count extremely low in miRbase data set with confirmed biological functions lacking.</p>
</fn>
<fn id="fnT2_2">
<label>b</label>
<p>Confirmed targets primarily based on luciferase reporter assays.</p>
</fn>
<fn id="fnT2_3">
<label>c</label>
<p>information from published reports, miRNA prediction programs, and Ingenuity Pathway analyses.</p>
</fn>
<fn id="fnT2_4">
<label>d</label>
<p>Obtained from uscs genome browser.</p>
</fn>
<fn id="fnT2_5">
<label>e</label>
<p>MiR-1286 only present in humans, orangutans, gorillas, and chimpanzees.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Genetic and epigenetic modifiers of 22q11.2 deletion syndrome with disease connections.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1" valign="top">Gene name</th>
<th align="center" colspan="1" rowspan="1" valign="top">Chromosome Location<xref ref-type="table-fn" rid="fnT3_1">
<sup>a</sup>
</xref>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">Function</th>
<th align="center" colspan="1" rowspan="1" valign="top">Human syndromes</th>
<th align="center" colspan="1" rowspan="1" valign="top">Mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<th colspan="5" rowspan="1" valign="top">Genes on chromosome 22q11.2</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TBX1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">T-box transcription factor regulates expression of 2000 genes</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2del</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interacts with histone3 methyltransferases, BAF60a, and SMAD1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DGCR8</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">MicroRNA binding protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2del</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epigenetically regulates gene expression through miRNAs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DGCR6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates neural crest migration</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD<sup>b</sup> (with PRODH deletion)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Negatively regulates <italic>TBX1</italic> expression</td>
</tr>
<tr>
<th align="left" colspan="5" rowspan="1" valign="top">Morphogens</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Retinoic acid</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morphogen involved in embryonic patterning</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2del-like</td>
<td align="left" colspan="1" rowspan="1" valign="top">Complexes retinoic acid receptor to regulate gene expression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gestational<break></break>Diabetes</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teratogen during pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2del-like</td>
<td align="left" colspan="1" rowspan="1" valign="top">Affects multiple developmental processes in the embryo, with the pharyngeal apparatus particularly sensitive</td>
</tr>
<tr>
<th align="left" colspan="5" rowspan="1" valign="top">Genes at other chromosomal locations</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KMT2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7q36.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histone methyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kleefstra syndrome 2<break></break>(neurodevelopmental disorder)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interacts with TBX1 and mono-methylates lysine 27 on histone 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BAF60a (SMARCD1)</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">12q13.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Component of the SWI-SNF chromatin remodeling complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Component of a chromosome remodeling complex that interacts with TBX1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MOZ</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">8p11.21</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histone acetyl transferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD<xref ref-type="table-fn" rid="fnT3_2">
<sup>b</sup>
</xref>, intellectual disability, and dysmorphic facial features</td>
<td align="left" colspan="1" rowspan="1" valign="top">positively regulated by RA and, in turn affects TBX1 expression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SMAD1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4q31.21</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling protein downstream of Bmp4</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Interacts with TBX1, which antagonizes its association with SMAD4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>JMJD1C</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">10q21.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histone demethylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett syndrome and intellectual<break></break>disability</td>
<td align="left" colspan="1" rowspan="1" valign="top">Demethylates lysine residues on histones</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MINA</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">3q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lysine-Specific Demethylase and Histidyl-Hydroxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preeclampsia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Demethylates lysine residues on histones</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KDM7A</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7q34</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lysine demethylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Demethylates lysine residues on histones</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RREB1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6p24.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zn finger transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates RAS-responsive elements</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SEC24C</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">10q22.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coat Protein II complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Involved in protein export from ER to Golgi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GLUT3</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">12p13.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glucose transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">-</td>
<td align="left" colspan="1" rowspan="1" valign="top">High affinity interaction with glucose to translocate across the membrane</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KANSL1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">17q21.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histone modification</td>
<td align="left" colspan="1" rowspan="1" valign="top">Koolen-De Vries syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear protein forming part of a complex that has histone acetyltransferase activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PAX1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">20p11.22</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Octofaciocervical syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates embryonic tissue patterning</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>VEGF</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6p21.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vascular endothelial growth factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetralogy of Fallot</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vascular endothelial growth factor supports cell growth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FGF8</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">10q24.32</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblast growth factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypogonadotropic hypogonadism 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblast growth factor supports cell growth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PDGFRα</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">4q12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Platelet derived growth factor receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates neural crest cell development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">7q36.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sonic hedgehog protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Holoprosencephaly 3, Microphthalmia with coloboma 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates Tbx1 expression and vertebrate organogenesis</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT3_1">
<label>a</label>
<p>Human chromosomal location.</p>
</fn>
<fn id="fnT3_2">
<label>b</label>
<p>Congenital heart disease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2">
<title>The Genetic and Epigenetic Regulation Coupled to <italic>TBX1</italic> Functions</title>
<p>The congenital malformations associated with 22q11.2del are often linked to the haploinsufficiency of <italic>TBX1</italic> (<xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B168">Zhang and Baldini, 2008</xref>; <xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). <italic>TBX1</italic> is expressed at specific regions in the pharyngeal apparatus and in the cardiac progenitors of the second heart field, regulating the expression of nearly 2000 genes (<xref ref-type="bibr" rid="B158">Xu et al., 2004</xref>; <xref ref-type="bibr" rid="B22">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). Many excellent reviews detailing the transcriptional role of <italic>TBX1</italic> in the patterning of the pharyngeal arches and pouches have been published (<xref ref-type="bibr" rid="B161">Yagi et al., 2003</xref>; <xref ref-type="bibr" rid="B167">Zemble et al., 2010</xref>; <xref ref-type="bibr" rid="B9">Bassett et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Fung et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Mcdonald-Mcginn et al., 2015</xref>; <xref ref-type="bibr" rid="B96">Meechan et al., 2015</xref>; <xref ref-type="bibr" rid="B4">Baldini et al., 2016</xref>; <xref ref-type="bibr" rid="B145">Sullivan, 2019</xref>). While one might expect that a simple haploinsufficiency of <italic>TBX1</italic> should consistently lead to similar congenital malformations, this is certainly not what happens. It is becoming apparent that genetic and epigenetic changes, both within and outside chromosome 22q11.2, can dramatically sway the clinical phenotypes of 22q11.2del (<xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B168">Zhang and Baldini, 2008</xref>; <xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>).</p>
<p>To understand how such genetic and epigenetic factors impact <italic>TBX1</italic> and how this may affect the clinical phenotypes requires some knowledge of how TBX1 functions. Recent evidence indicates that <italic>TBX1</italic> interacts with members of the Histone-lysine N-methyltransferase (KMT2)-family (<xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). The KMT2 enzymes activate transcription by mono-methylating lysine residues on Histone 3 (H3K4) on chromatin (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). The TBX1-KMT2 complex regulates the low-level expression of thousands of genes by marking chromatin. In addition, TBX1 interacts with the SWI-SNF-like BAF complex to support chromatin remodeling (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B22">Chen et al., 2012</xref>). These two types of interactions would suggest that small fluctuations in the levels of TBX1 could modulate the expression of thousands of transcripts, with those impacted likely stochastic from cell to cell. Thus, variations in TBX1 levels could underlie the severity of the malformations in the pharyngeal region. What patient to patient differences exist that could affect <italic>TBX1</italic> expression? One is with <italic>DiGeorge Critical Region 6 (DGCR6</italic>), a gene also encoded on the frequently deleted segment of chromosome 22q11.2. DGCR6 down-regulates <italic>TBX1</italic>, impacting neural crest migration within the pharyngeal region (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>, <xref ref-type="table" rid="T3">
<bold>Table 3</bold>
</xref>) (<xref ref-type="bibr" rid="B48">Groot et al., 2004</xref>; <xref ref-type="bibr" rid="B21">Chakraborty et al., 2012</xref>). As neural crest cells establish the vasculature of the pharyngeal arch arteries along with the capsule of the thymus, changes in their location would affect the morphogenesis of this region. While the transcript levels of <italic>DGCR6</italic> as well as its homolog, <italic>DGCR6L</italic> should be reduced 50% due to their respective haploinsufficiency in 22q11.2del patients, their levels are extremely variable in 22q11.2del patients (<xref ref-type="bibr" rid="B21">Chakraborty et al., 2012</xref>). Some individuals actually have much higher levels of DGCR6 compared to normal controls (<xref ref-type="bibr" rid="B21">Chakraborty et al., 2012</xref>). Such dramatic expression variations in <italic>DGCR6</italic> and <italic>DGCR6L</italic> are epigenetically determined as there is no evidence of maternal or paternal imprinting (<xref ref-type="bibr" rid="B21">Chakraborty et al., 2012</xref>). Noteworthy, either deletions or duplications of <italic>DGCR6</italic>, in combination with an adjacent gene, <italic>PRODH</italic>, are linked to CHD (<xref ref-type="bibr" rid="B45">Gao et al., 2015b</xref>). These findings suggest that fluctuations in DGCR6 will affect <italic>TBX1</italic> levels, and as a consequence, patterning of the pharyngeal region. While most TBX1 is localized in the nucleus, some is present in the cytosol where a portion is complexed with SMAD1 (<xref ref-type="bibr" rid="B41">Fulcoli et al., 2009</xref>). This interaction limits the levels of a SMAD1-SMAD4 complex, preventing effective Bone Morphogenic Protein 4 (BMP4) signaling (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B41">Fulcoli et al., 2009</xref>). As Bmp4 has a critical role in the septation of the outflow tracts and remodeling of the arch arteries, disruption of its signaling by modulating TBX1 levels is certain to impact these processes (<xref ref-type="bibr" rid="B86">Liu et al., 2004</xref>). Bmp4 also regulates early thymus and parathyroid morphogenesis (<xref ref-type="bibr" rid="B46">Gordon et al., 2008</xref>). TBX1 interacts with several additional proteins, albeit the role of these complexes are less well-defined (<xref ref-type="bibr" rid="B4">Baldini et al., 2016</xref>). In summary, alterations in the levels and/or subcellular distribution of TBX1 will certainly impact the severity of the congenital problems.</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>Molecular pathways intersecting with <italic>TBX1</italic> with the potential to modulate the clinical severity and penetrance of 22q11.2del. The expression of <italic>TBX1</italic>, a key gene coupled to the patterning of the pharyngeal apparatus, is positively regulated by members of the Fox-family of transcription factors and MOZ. Negative regulators of TBX1 include the defined teratogens, retinoic acid (RA), gestational diabetes, and miR-96 and miR-451a, the latter two miRNAs that target the 3' untranslated region of TBX1, resulting in its degradation. While most TBX1 resides in the nucleus, wherein it can regulate gene expression, a fraction of TBX1 is localized in the cytosol, where it negatively impacts bone morphogenic protein signaling <italic>via</italic> a complex with SMAD4.</p>
</caption>
<graphic xlink:href="fgene-10-01365-g002"></graphic>
</fig>
<p>The consequence of varying <italic>TBX1</italic> levels in relation to the severity of the congenital malformations in humans is further supported by comparisons with the diverse 22q11.2del mouse models. Multiple mouse lines were originally created with deletions of varying length on chromosome 16 (orthologous to human chromosome 22q11.2) to identify causal genes in the disorder (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>) (<xref ref-type="bibr" rid="B59">Jones et al., 1999</xref>; <xref ref-type="bibr" rid="B65">Kimber et al., 1999</xref>; <xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B116">Puech et al., 2000</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>). Comparing the phenotypes in several such mouse lines confirms that changes in <italic>Tbx1</italic> levels affects the extent and severity of the CHD, thymic hypoplasia, and hypoparathyroidism (<xref ref-type="bibr" rid="B65">Kimber et al., 1999</xref>; <xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B116">Puech et al., 2000</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B81">Lindsay and Baldini, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B147">Taddei et al., 2001</xref>). Yet, relative to humans, mice actually have a lower penetrance of several of the congenital defects in the setting of either the 22q11.2del or just a <italic>Tbx1</italic> haploinsufficiency, most evident with the number of embryos exhibiting a hypoplasia of the thymus. This corresponds to the levels of <italic>TBX1,</italic> since reducing <italic>Tbx1</italic> to 35% normal in the embryos results in a highly penetrant thymic hypoplasia (<xref ref-type="bibr" rid="B168">Zhang and Baldini, 2008</xref>). Are there strategies to circumvent the reduced levels of <italic>TBX1</italic>? Yes, as treating pregnant mice with a histone demethylase inhibitor (tranylcypromine) can increase the methylation levels of H3K4 and partially rescue the cardiovascular anomalies in the <italic>Tbx</italic>1-mutant embryos (<xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>).</p>
<p>There are several additional regulators of <italic>TBX1</italic> expression that likely have a bearing on 22q11.2del. One is retinoic acid (RA), a metabolite of vitamin A that functions as a natural morphogen involved in the patterning of the 3<sup>rd</sup>, 4<sup>th</sup>, and 6<sup>th</sup> pharyngeal arch arteries and 3<sup>rd</sup> PP (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B110">Niederreither et al., 2003</xref>; <xref ref-type="bibr" rid="B153">Vermot et al., 2003</xref>; <xref ref-type="bibr" rid="B24">Cipollone et al., 2006</xref>; <xref ref-type="bibr" rid="B155">Voss et al., 2012</xref>). Vitamin A deficiency during pregnancy remains a public health issue in developing countries due to its impact on the developing fetus, particularly eye development (<xref ref-type="bibr" rid="B10">Bastos Maia et al., 2019</xref>). High levels of RA can act as a teratogen that causes overlapping 22q11.2del-like phenotypes. This was discovered after pregnant mothers were prescribed RA (tretinoin, isotretinoin) as a clinical treatment for acne, with their infants born with 22q11.2-like congenital malformations (<xref ref-type="bibr" rid="B69">Kucera, 1971</xref>; <xref ref-type="bibr" rid="B72">Lammer et al., 1985</xref>; <xref ref-type="bibr" rid="B85">Lipson et al., 1993</xref>; <xref ref-type="bibr" rid="B90">Markert et al., 2007</xref>; <xref ref-type="bibr" rid="B102">Mills, 2010</xref>; <xref ref-type="bibr" rid="B127">Sacks et al., 2012</xref>; <xref ref-type="bibr" rid="B18">Browne et al., 2014</xref>). Mechanistically, RA suppresses <italic>TBX1</italic> expression (<xref ref-type="bibr" rid="B123">Roberts et al., 2005</xref>; <xref ref-type="bibr" rid="B125">Ryckebusch et al., 2010</xref>; <xref ref-type="bibr" rid="B137">Smith and Tallquist, 2010</xref>). This was confirmed by using mice created with a haploinsufficiency of <italic>retinaldehyde dehydrogenase 2</italic> (<italic>Rald2</italic>), an enzyme required for RA synthesis. <italic>Rald2<sup>+/-</sup></italic> embryos produce less RA, increasing the levels of <italic>Tbx1</italic>. In the setting of a <italic>Tbx1</italic> haploinsufficiency, the severity of the heart defects was reduced in the Rald2<sup>+/-</sup> background (<xref ref-type="bibr" rid="B125">Ryckebusch et al., 2010</xref>). RA also acts to epigenetically alter chromatin accessibility by positively regulating the expression of <italic>Monocytic Leukemia Zinc Finger</italic> (<italic>MOZ/Myst3/Kat6a</italic>), a histone acetyltransferase. MOZ, in turn, positively regulates TBX1 levels, with <italic>Moz</italic>-knock-out mice and those with loss-of-function mutations having less <italic>Tbx1</italic>, along with <italic>Tbx2</italic>, <italic>Tbx5</italic>, and <italic>Tbx9</italic> (<xref ref-type="bibr" rid="B123">Roberts et al., 2005</xref>; <xref ref-type="bibr" rid="B57">Jenkinson et al., 2007</xref>; <xref ref-type="bibr" rid="B155">Voss et al., 2012</xref>). In humans, heterozygous MOZ mutations lead to a syndromic disorder comprising CHD, intellectual disability, and dysmorphic facial features (<xref ref-type="bibr" rid="B150">Tham et al., 2015</xref>). In summary, too much RA leads to similar clinical phenotypes as 22q11.2del, likely through its ability to reduce the expression of various TBX-family members including <italic>TBX1</italic> (<xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B40">Ensenauer et al., 2003</xref>; <xref ref-type="bibr" rid="B104">Mokate et al., 2006</xref>; <xref ref-type="bibr" rid="B173">Zweier et al., 2007</xref>; <xref ref-type="bibr" rid="B168">Zhang and Baldini, 2008</xref>).</p>
<p>Gestational diabetes is a distinct teratogen affecting pregnancy, with newborns having congenital features overlapping with 22q11.2del (<xref ref-type="bibr" rid="B69">Kucera, 1971</xref>; <xref ref-type="bibr" rid="B102">Mills, 2010</xref>; <xref ref-type="bibr" rid="B127">Sacks et al., 2012</xref>; <xref ref-type="bibr" rid="B34">Dornemann et al., 2017</xref>). In fact, about 18% of infants with a thymic aplasia who did not have deletions on chromosome 22q11.2 and required a thymic tissue transplant were born to mothers with a clinical history of gestational diabetes (<xref ref-type="bibr" rid="B90">Markert et al., 2007</xref>). Experimental induction of diabetes in pregnant mice and rats similarly results in a thymic hypoplasia along with intrauterine growth impairment (<xref ref-type="bibr" rid="B113">Padmanabhan and Shafiullah, 2004</xref>). So how might elevated blood sugar levels lead to 22q11.2del-like presentations? While this is not yet known, there are some emerging clues. Pregestational diabetes reduces the expression of a regulator of RA, <italic>Cytochrome P450 family 26 subfamily A member 1</italic> (<italic>Cyp26a1</italic>), in the caudal region (tailbud) of developing embryos (<xref ref-type="bibr" rid="B77">Lee et al., 2017</xref>). Cyp26a1 catabolizes RA in various tissues to control the levels of this product, and consequently morphogenesis. One speculation is that elevations in blood sugar levels during gestation may increase the levels of RA in the pharyngeal region, thereby diminishing <italic>TBX1</italic> levels. It is also known that gestational diabetes affects histone modifications and DNA methylation patterns in fetal cord blood, implying an epigenetic effect that may contribute to the 22q11.del phenotypes (<xref ref-type="bibr" rid="B52">Haertle et al., 2017</xref>). These emerging findings suggest that better control of gestational diabetes may aid in diminishing the severity of certain congenital malformations, particularly for embryos who have 22q11.2del.</p>
</sec>
<sec id="s3">
<title>DiGeorge Syndrome Critical Region 8 and microRNA Contributions to 22q11.2del</title>
<p>
<italic>DiGeorge Syndrome Critical Region 8 (DGCR8)</italic> is another key gene whose haploinsufficiency in 22q11.2del patients can influence the severity of their clinical problems. It is a nuclear miRNA binding protein required for the biogenesis of microRNAs (miRNAs) (<xref ref-type="bibr" rid="B73">Landthaler et al., 2004</xref>; <xref ref-type="bibr" rid="B166">Yi et al., 2009</xref>; <xref ref-type="bibr" rid="B131">Schofield et al., 2011</xref>). MiRNAs are a family of ~2000 small noncoding RNAs (18-22 nucleotides) that bind to diverse mRNA transcripts, targeting the latter for degradation (<xref ref-type="bibr" rid="B79">Lewis et al., 2005</xref>; <xref ref-type="bibr" rid="B49">Grosshans and Filipowicz, 2008</xref>; <xref ref-type="bibr" rid="B88">Lodish et al., 2008</xref>; <xref ref-type="bibr" rid="B6">Bartel, 2009</xref>; <xref ref-type="bibr" rid="B157">Xiao and Rajewsky, 2009</xref>; <xref ref-type="bibr" rid="B67">Krol et al., 2010</xref>; <xref ref-type="bibr" rid="B129">Salmena et al., 2011</xref>; <xref ref-type="bibr" rid="B2">Alles et al., 2019</xref>). DGCR8 binds to primary miRNA (pri-miRNA) transcripts in the nucleus in conjunction with DROSHA, an endoribonuclease (Ribonuclease III) that cleaves pri-miRNAs into precursor miRNAs (pre-miRNAs) (<xref ref-type="bibr" rid="B75">Lee et al., 2003</xref>; <xref ref-type="bibr" rid="B73">Landthaler et al., 2004</xref>). These pre-miRNAs are subsequently exported from the nucleus for further processing into miRNAs. Importantly, such miRNAs regulate cellular homeostasis in almost all tissues, are very stress responsive, and facilitate tissue repair and regeneration (<xref ref-type="bibr" rid="B6">Bartel, 2009</xref>; <xref ref-type="bibr" rid="B78">Leung and Sharp, 2010</xref>; <xref ref-type="bibr" rid="B98">Mendell and Olson, 2012</xref>). Thus, a 50% reduction in <italic>DGCR8</italic> expression due to 22q11.2del would be predicted to modulate the expression of hundreds of miRNAs. Consistent with this, 22q11.2del patients have a miRNA dysregulation in the peripheral blood, with many miRNAs reduced in expression relative to normal controls (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>) (<xref ref-type="bibr" rid="B31">De La Morena et al., 2013</xref>). This dysregulation includes a hypervariable miRNA expression pattern that differs from patient to patient, and interestingly, a coordinated expression of multiple distinct clusters of miRNAs among most 22q11.2del individuals (<xref ref-type="bibr" rid="B31">De La Morena et al., 2013</xref>; <xref ref-type="bibr" rid="B132">Sellier et al., 2014</xref>). The distinct miRNA clustering may emanate from physiological responses to the clinical problems.</p>
<p>In mouse models, the haploinsufficiency of <italic>Dgcr8</italic> causes a 30-50% reduction in the overall expression of miRNAs screened in neurons (<xref ref-type="bibr" rid="B140">Stark et al., 2008</xref>). These miRNA losses worsen as the mice age. One consequence so far described is an abnormal calcium response in the hippocampal pyramidal neurons (CA3-CA1) that leads to premature synaptic neurotransmitter release (<xref ref-type="bibr" rid="B38">Earls et al., 2010</xref>; <xref ref-type="bibr" rid="B39">Earls et al., 2012</xref>). Such synaptic disruptions are characteristic of schizophrenia, a frequent presentation in the 22q11.2del patients (<xref ref-type="bibr" rid="B60">Karayiorgou et al., 1995</xref>; <xref ref-type="bibr" rid="B61">Karayiorgou et al., 2010</xref>; <xref ref-type="bibr" rid="B159">Xu et al., 2013</xref>). The neurological miRNA deficiencies in the <italic>Dgcr8</italic>
<sup>+/-</sup> mice are similar in the mouse models of 22q11.2del, establishing that a 50% reduction in <italic>Dgcr8</italic> is key to the miRNA losses (<xref ref-type="bibr" rid="B39">Earls et al., 2012</xref>). Interestingly, DGCR8 has functions unrelated to miRNA processing, instead regulating splicing processes in embryonic stem cells, a finding that may reveal more complexities concerning 22q11.2del (<xref ref-type="bibr" rid="B25">Cirera-Salinas et al., 2017</xref>).</p>
<p>In addition to <italic>DGCR8</italic>, the frequently deleted segment of chromosome 22q11.2 leads to a haploinsufficiency of 7 miRNAs (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>, <xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). Six are clustered near <italic>DGCR8</italic>. MiR-185 has the strongest connection to the clinical phenotypes of 22q11.2del, detected at 0.4 X normal levels in peripheral blood samples (<xref ref-type="bibr" rid="B31">De La Morena et al., 2013</xref>). It is expressed in cardiac tissue, immune cells, and in the brain, targeting <italic>Marginal Zone B1 Protein</italic> (<italic>Mzb1</italic>), <italic>Bruton’s Tyrosine Kinase</italic> (<italic>Btk</italic>), <italic>Calmodulin Kinase 4</italic> (<italic>Camk4</italic>), <italic>Sarco/endoplasmic Reticulum Ca<sup>2+-</sup>ATPase</italic> (<italic>Serca2</italic>), and <italic>Nuclear Factor of Activated T cells 3c</italic> (<italic>Nfat3c</italic>) (<xref ref-type="bibr" rid="B39">Earls et al., 2012</xref>; <xref ref-type="bibr" rid="B12">Belkaya et al., 2013</xref>; <xref ref-type="bibr" rid="B64">Kim et al., 2015</xref>). A common theme regarding these miR-185 targets is calcium signaling, central to many cellular processes (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). The haploinsufficiency of miR-185 in hippocampal neurons results in premature synaptic transmissions, partly through changes in <italic>Serca2</italic> and <italic>Nfatc</italic> levels, with these genes controlling or being regulated by intracellular calcium changes, respectively (<xref ref-type="bibr" rid="B39">Earls et al., 2012</xref>). Moreover, enforced expression of miR-185 in thymocytes attenuates T cell development by a disruption of the T cell receptor controlled calcium response (<xref ref-type="bibr" rid="B12">Belkaya et al., 2013</xref>). MiR-185 also controls cardiac hypertrophy by targeting <italic>Nfatc</italic> in myocardial cells (<xref ref-type="bibr" rid="B64">Kim et al., 2015</xref>). In B cells, the haploinsufficiency of miR-185 is linked to increased autoantibody production, and this may involve increases in the levels of <italic>Bruton’s tyrosine kinase</italic> (Btk), a target of miR-185 (<xref ref-type="bibr" rid="B13">Belver et al., 2010</xref>). Notably, 22q11.2del patients can have clinical phenotypes related to the disruption of all of these pathways; abnormal neurotransmitter release, low T cell output, cardiac hypertrophy, and autoimmunity. Two additional miRNAs, miR-3618 and miR-1306, are located at the 5’ untranslated region and within exon 1 of <italic>DGCR8</italic>, respectively (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). While miR-1306 is encoded in most eukaryotic species, miR-3618 is restricted to primates (<xref ref-type="bibr" rid="B99">Merico et al., 2014</xref>). MiR-1306 targets <italic>F-box/Leucine rich repeat 5</italic> (<italic>FBLX5</italic>), affecting epithelial to mesenchymal transitions and <italic>TGF beta-receptor 2</italic>, which is involved in the TGF-beta-SMAD4 signaling process (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B53">He et al., 2018</xref>; <xref ref-type="bibr" rid="B164">Yang et al., 2019</xref>). Other haploinsufficient miRNAs include miR-1286, selectively encoded in advanced primates, with <italic>in situ</italic> hybridization revealing its expression in the occipital cortex (<xref ref-type="bibr" rid="B111">Nowakowski et al., 2018</xref>). MiR-649, located within the LCRD segment of 22q11.2, targets <italic>MALT1</italic>, a component of a complex of proteins that activate NF-κB in lymphocytes. MiR-649 enhances Herpes Simplex Virus susceptibility, likely through effects on the NF-κB pathway (<xref ref-type="bibr" rid="B170">Zhang et al., 2017</xref>). Several miRNA target prediction programs have been applied to the 7 miRNAs encoded on chromosome 22q11.1 to identify linked pathways that relate to clinical phenotypes. An overlapping set of these miRNAs can target <italic>TBX1</italic>, <italic>KAT8 regulatory NSL complex subunit 1</italic> (<italic>KANSL1</italic>), <italic>Glucose Transporter 3</italic> (<italic>GLUT3</italic>, SLC2A3), and <italic>Ras Responsive Element Binding protein 1</italic> (<italic>RREB1</italic>) (<xref ref-type="bibr" rid="B14">Bertini et al., 2017</xref>; <xref ref-type="bibr" rid="B74">León et al., 2017</xref>). Several of these targets are discussed in a subsequent section in relation to their roles in 22q11.2del. Four of the miRNAs regulate transcripts linked to schizophrenia (<xref ref-type="bibr" rid="B99">Merico et al., 2014</xref>).</p>
<p>Interestingly, there are 2 miRNAs encoded on other chromosomes that target <italic>TBX1</italic>. One is miR-96, mutations in which cause a non-syndromic hearing loss in humans (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref ref-type="bibr" rid="B97">Mencia et al., 2009</xref>; <xref ref-type="bibr" rid="B44">Gao et al., 2015a</xref>). In a feed-back loop, TBX1 represses miR-96, suggesting that alterations in the levels of <italic>TBX1</italic> may impact hearing loss, consistent with the auditory problems reported for some but not all 22q11.2del patients (<xref ref-type="bibr" rid="B44">Gao et al., 2015a</xref>). A second is miR-451, which is involved in wound healing and has been shown to target <italic>TBX1</italic> transcripts (<xref ref-type="bibr" rid="B146">Sun and Jiang, 2018</xref>; <xref ref-type="bibr" rid="B108">Munk et al., 2019</xref>). Ongoing research efforts to identify the different miRNA targets are uncovering multiple intersecting pathways connected with the developmental and neurological manifestation of 22q11.2del (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). The fact that the expression of many distinct miRNAs fluctuate over time and are variable from patient to patient likely explains some of the post-natal complications that differ among 22q11.2del patients (<xref ref-type="bibr" rid="B31">De La Morena et al., 2013</xref>). Future directions for such patients may be clinical interventions to improve DGCR8 functions, with recent experiments reporting that protoporphyrins can enhance miRNA biogenesis in DGCR8-haploinsufficient cells (<xref ref-type="bibr" rid="B5">Barr et al., 2015</xref>; <xref ref-type="bibr" rid="B126">Sachar et al., 2016</xref>).</p>
</sec>
<sec id="s4">
<title>Emerging Noncoding RNAs and Their Potential Roles in 22q11.2del</title>
<p>Adding further complexity to 22q11.del are the 12 long noncoding RNAs (lncRNAs) embedded in the frequently deleted segment of chromosome 22q11.2 (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). LncRNAs can act as scaffold RNAs, transcriptional assembly hubs, regulators of chromatin accessibility and genome stability (<xref ref-type="bibr" rid="B3">Angrand et al., 2015</xref>; <xref ref-type="bibr" rid="B76">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="B117">Quinn and Chang, 2016</xref>; <xref ref-type="bibr" rid="B36">Du et al., 2019</xref>). They exhibit limited evolutionary sequence conservation and are generally expressed at levels much lower than protein coding genes (<xref ref-type="bibr" rid="B20">Cesana et al., 2011</xref>; <xref ref-type="bibr" rid="B63">Keniry et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Dey et al., 2014</xref>; <xref ref-type="bibr" rid="B162">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="B171">Zhou et al., 2015</xref>). In spite of the accumulating discoveries detailing the functions of numerous lncRNAs, relatively little is known about the 12 that are frequently deleted on chromosome 22q11.2. As the curation of lncRNAs in the human genome is incomplete, additional lncRNAs are likely to be identified on chromosome 22q11.2, while some of those currently compiled may be invalidated. Four lncRNAs, DGCR5, DGCR9, LINC01311, and LINC00896 have high enough RPKM values (Reads per Kilobase of transcripts per Million mapped reads) to suggest functionality, particularly as each is expressed in the biologically relevant tissue (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). Findings to date suggest that several of these lncRNAs could affect the clinical presentations of 22q11.2del, but this is only inferred based on what is known about these lncRNAs in non-22q11.2del patients. DGCR5 and Lnc00896 were up-regulated 9- and 5- fold in patients with lung adenocarcinomas, implying a role in cell growth and survival (<xref ref-type="bibr" rid="B143">Sui et al., 2016</xref>). In a separate study of lung cancer patients, DGCR5 was down-regulated, and its target, miR-1180, was increased in expression (<xref ref-type="bibr" rid="B23">Chen et al., 2017</xref>). Elevations in miR-1180 reduces apoptosis (<xref ref-type="bibr" rid="B149">Tan et al., 2016</xref>). DGCR5 also functions as a competing RNA for miR-23b, causes increases in the targets of this miRNA, PTEN and BTG1 (<xref ref-type="bibr" rid="B160">Xu et al., 2019</xref>). Lnc00896 is regulated by miR-139, although the importance of this remains unknown (<xref ref-type="bibr" rid="B143">Sui et al., 2016</xref>). DGCR11 is up-regulated 2-fold in hepatocellular cancers, again its role remaining undefined (<xref ref-type="bibr" rid="B169">Zhang et al., 2015</xref>). AC004471.10 has a protein coding analog in both the murine and cow genomes, termed Testes Specific Serine Kinase 2 (TSSK2), and lies downstream of TSSK1A (<xref ref-type="bibr" rid="B87">Liu et al., 2017</xref>). The significance of this lncRNA-protein coding region homology remains unclear. XXbac-B444P24.14 was identified in a screen for differentially regulated lncRNAs in multiple myeloma (<xref ref-type="bibr" rid="B124">Ronchetti et al., 2018</xref>). As with many of the annotated lncRNAs currently curated in the human genome, future studies will need to ascertain the functional contributions of those haploinsufficient due to 22q11.2del and assess the consequences of this on the clinical phenotypes.</p>
<p>Along with the miRNAs and lncRNAs encoded on chromosome 22q11.2 are two small nucleolar RNAs (snoRNAs), SNORA15, and SNORA77 (<xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>). Ranging in size from 60–300 nucleotides, snoRNAs are generated from intronic regions. They assemble with a set of proteins in the nucleolus to facilitate ribosomal RNA processing (<xref ref-type="bibr" rid="B95">Mcmahon et al., 2015</xref>). Both SNORA15 and SNORA77 regulate the conversion of uridines to pseudouridines to improve the folding and stabilization of rRNAs (<xref ref-type="bibr" rid="B37">Dupuis-Sandoval et al., 2015</xref>). The expression of SNORA15 is altered in cancer, but again how the haploinsufficiency of either of the two snoRNAs affects biological functions in the context of 22q11.2del remains an open question (<xref ref-type="bibr" rid="B163">Yang et al., 2017</xref>).</p>
<p>Taken together, it is clear that the haploinsufficiency of diverse noncoding RNAs and the extensive dysregulation of the miRNAs within this group will impact both developmental processes during embryogenesis and post-natal cardiac, immune, and neurological functions. Identifying the pathways affected by these diverse noncoding RNAs may better guide clinical management of the 22q11.2del patients.</p>
</sec>
<sec id="s5">
<title>Diverse Genetic Polymorphisms Affecting 22q11.2del Phenotypes</title>
<p>Patients with both deletions and duplications of chromosome 22q11.2 and those with loss- or gain- of-function mutations in <italic>TBX1</italic> often have overlapping congenital problems that still vary in severity (<xref ref-type="bibr" rid="B40">Ensenauer et al., 2003</xref>; <xref ref-type="bibr" rid="B161">Yagi et al., 2003</xref>; <xref ref-type="bibr" rid="B158">Xu et al., 2004</xref>; <xref ref-type="bibr" rid="B141">Stoller and Epstein, 2005</xref>; <xref ref-type="bibr" rid="B173">Zweier et al., 2007</xref>; <xref ref-type="bibr" rid="B22">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B120">Reeh et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Baldini et al., 2016</xref>). Moreover, identical mutations in <italic>TBX1</italic> present among several members of the same family resulted in distinct clinical phenotypes (<xref ref-type="bibr" rid="B161">Yagi et al., 2003</xref>). These findings further support the idea that selected genetic and/or epigenetic changes can impact the severity of the clinical complications for 22q11.2del patients (<xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>; <xref ref-type="bibr" rid="B147">Taddei et al., 2001</xref>; <xref ref-type="bibr" rid="B158">Xu et al., 2004</xref>; <xref ref-type="bibr" rid="B168">Zhang and Baldini, 2008</xref>; <xref ref-type="bibr" rid="B22">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B4">Baldini et al., 2016</xref>; <xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). This is evident with recent studies revealing numerous genetic differences among the 22q11.2del patients that lie outside the affected locus, potentially affecting disease severity and penetrance (<xref ref-type="bibr" rid="B51">Guo et al., 2015</xref>; <xref ref-type="bibr" rid="B103">Mlynarski et al., 2015</xref>; <xref ref-type="bibr" rid="B29">Consortium et al., 2016</xref>; <xref ref-type="bibr" rid="B74">León et al., 2017</xref>). Identified by targeted exome, whole genome, and RNA sequencing strategies, SNPs, copy number variants (CNVs), DNA coding sequence differences and noncoding alterations have been discovered. For example, whole exome sequencing of 184 different 22q11.2del patients was used to identify rare deleterious SNPs (<xref ref-type="bibr" rid="B51">Guo et al., 2015</xref>). This screen uncovered polymorphisms in several genes selectively in those 22q11.2del patients with CHD. Several of the SNPs are in genes that regulate histone demethylation, <italic>Jumonji Domain Containing 1C</italic> (<italic>JMJD1C</italic>), <italic>MYC Induced Nuclear Antigen</italic> (<italic>MINA</italic>), and <italic>Lysine-Specific Demethylase</italic> (<italic>KDM7A</italic>). This once again reveals an epigenetic component to 22q11.2del. SNPs have also been reported in <italic>Ras Responsive Element Binding protein 1</italic> (<italic>RREB1</italic>) and <italic>SEC24 family member C</italic> (<italic>SEC24C</italic>) selectively in the 22q11.2del with CHD.</p>
<p>CNV analyses have revealed a connection between those 22q11.2del patients who have CHD with a duplication of <italic>GLUT3</italic> (also known as <italic>SLC2A3</italic>), located on chromosome 12p13.3 (<xref ref-type="bibr" rid="B103">Mlynarski et al., 2015</xref>). Its duplication is only pathogenic in conjunction with 22q11.2del (Odds ratio = 5.08) (<xref ref-type="bibr" rid="B103">Mlynarski et al., 2015</xref>). Of the 5 glucose transporters, GLUT3 has the highest affinity and greatest transport capacity for glucose (<xref ref-type="bibr" rid="B136">Simpson et al., 2008</xref>). An independent screen for CNVs in 253 22q11.2del patients identified a duplication of the first 3 exons of the <italic>KANSL1</italic> (chromosome 17q21.31), contributing to an increased odds ratio for CHD (OR = 2.75) (<xref ref-type="bibr" rid="B74">León et al., 2017</xref>). KANSL1 is part of protein complex that acetylates histones to regulate gene expression (<xref ref-type="bibr" rid="B105">Moreno-Igoa et al., 2015</xref>). How the duplication of 3 exons of <italic>KANSL1</italic> increases the likelihood of CHD remains uncertain, but a recurring theme of histone modifications in the context of 22q11.2del is evident. <italic>KANSL1</italic> is also linked to gene pathways regulated by miRNAs, discussed in a preceding section. In a separate screen for CNVs in miRNAs, deletions and duplications of 11 distinct miRNAs were uncovered in 22q11.2del patients, with at least 1 miRNA affected per individual (<xref ref-type="bibr" rid="B14">Bertini et al., 2017</xref>).</p>
</sec>
<sec id="s6">
<title>Mouse Studies Revealing Additional Candidate Genes Influencing 22q11.2del</title>
<p>Complementing the human sequencing are various mouse studies suggesting additional candidate genes could affect the penetrance and/or severity of 22q11.2del. Among these are <italic>Vascular endothelial growth factor</italic> (<italic>Vegf</italic>), <italic>Fibroblast growth factor 8</italic> (<italic>Fgf8</italic>), and <italic>Platelet derived growth factor receptor</italic> (<italic>Pdgfr</italic>) (<xref ref-type="table" rid="T3">
<bold>Table 3</bold>
</xref>) (<xref ref-type="bibr" rid="B154">Vitelli et al., 2002</xref>; <xref ref-type="bibr" rid="B139">Stalmans et al., 2003</xref>; <xref ref-type="bibr" rid="B155">Voss et al., 2012</xref>). In mice, reductions in <italic>Vegf</italic> recapitulate the cardiac defects of 22q11.2del (<xref ref-type="bibr" rid="B139">Stalmans et al., 2003</xref>; <xref ref-type="bibr" rid="B71">Lambrechts et al., 2005</xref>). Mice haploinsufficient in both <italic>Tbx1</italic> and <italic>Fgf8</italic> (<italic>Tbx1</italic>
<sup>+/−</sup>
<italic>Fgf8</italic>
<sup>+/−</sup>) have a higher penetrance of aortic arch artery defects, with Tbx1 regulating <italic>Fgf8</italic> expression (<xref ref-type="bibr" rid="B154">Vitelli et al., 2002</xref>). These results led one group of investigators to speculate that <italic>VEGF</italic> and/or <italic>FGF8</italic> expression differences in humans could affect the severity of clinical phenotypes in 22q11.2del (<xref ref-type="bibr" rid="B139">Stalmans et al., 2003</xref>; <xref ref-type="bibr" rid="B71">Lambrechts et al., 2005</xref>). In one case study, a family with low levels of <italic>VEGF</italic> had several members diagnosed with Tetralogy of Fallot, which occurs in patients with 22q11.2del (<xref ref-type="bibr" rid="B71">Lambrechts et al., 2005</xref>). Another possible epigenetic regulator is <italic>Pdgfrα</italic>, which is expressed in neural crest cells throughout the pharyngeal region (<xref ref-type="bibr" rid="B148">Tallquist and Soriano, 2003</xref>; <xref ref-type="bibr" rid="B137">Smith and Tallquist, 2010</xref>). Its targeted elimination in mice causes very similar cardiac anomalies as reported for 22q11.2del (<xref ref-type="bibr" rid="B148">Tallquist and Soriano, 2003</xref>). Interestingly, <italic>Pdgfrβ</italic> appears to provide some functional redundancy in the absence of <italic>Pdgfrα</italic>, as the elimination of both receptors in neural crest cells results in a near complete penetrance of the cardiac anomalies along with a thymic aplasia (<xref ref-type="bibr" rid="B148">Tallquist and Soriano, 2003</xref>; <xref ref-type="bibr" rid="B122">Richarte et al., 2007</xref>; <xref ref-type="bibr" rid="B137">Smith and Tallquist, 2010</xref>). Other candidate genes identified in mouse models include <italic>Pax1</italic>, <italic>Pax3</italic>, <italic>Rarb</italic>, <italic>Cyp26b1</italic>, <italic>Hoxa3</italic>, <italic>Hoxb1</italic>, <italic>Hoxb3</italic>, <italic>Hoxb4</italic>, and <italic>Hoxd4</italic>, each of which is expressed either throughout the entire pharyngeal apparatus or at selected regions. Loss-of-function mutations in human <italic>PAX1</italic> cause otofaciocervical syndrome coupled with immunodeficiency, the latter due to the resulting thymic aplasia (<xref ref-type="bibr" rid="B115">Pohl et al., 2013</xref>; <xref ref-type="bibr" rid="B114">Paganini et al., 2017</xref>). In summary, it is likely that polymorphisms and/or mutations that impact the expression/function of many of the genes coupled to the patterning of the pharyngeal apparatus as well as neurological processes will be identified based on their capacity to modulate the clinical manifestations of 22q11.2del.</p>
<p>A further observation from the different mouse models is the strain dependent severity of the CHD and thymic anomalies, which reveals the effects of genetic differences (<xref ref-type="bibr" rid="B147">Taddei et al., 2001</xref>). Thus, the original 129SvEv background in which most of the 22q11.2del mouse models were generated has the lowest penetrance of the congenital malformations (<xref ref-type="bibr" rid="B65">Kimber et al., 1999</xref>; <xref ref-type="bibr" rid="B82">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Jerome and Papaioannou, 2001</xref>; <xref ref-type="bibr" rid="B83">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="B100">Merscher et al., 2001</xref>). Backcrossing these mice onto the C57BL/6 background yields a more penetrant phenotype, particularly in regards to the thymic hypoplasia (<xref ref-type="bibr" rid="B147">Taddei et al., 2001</xref>). Of relevance, this strain of mice is more sensitive to stress, as assessed by the higher corticosterone levels in the blood (<xref ref-type="bibr" rid="B118">Ramírez-Rosas et al., 2019</xref>). Children with 22q11.2del have higher levels of cortisol relative to age-matched controls (<xref ref-type="bibr" rid="B56">Jacobson et al., 2016</xref>). Elevations in cortisol can reduce T cell output from the thymus (<xref ref-type="bibr" rid="B11">Belkaya et al., 2011</xref>). Studies in a zebrafish model suggest elevated cortisol levels during embryogenesis are detrimental to cardiac functions (<xref ref-type="bibr" rid="B109">Nesan and Vijayan, 2012</xref>). The connection between stress, tissue repair and regeneration, and miRNAs is well-established, and the dysregulation of miRNAs described above will likely be impacted by the cortisol levels in 22q11.2del patients. Finally, the severity and penetrance of the congenital malformations may be related to epigenetic modifiers that affect tissue repair and regeneration during embryogenesis. Notably, the 4<sup>th</sup> pharyngeal arch artery is either missing and/or poorly developed in nearly 100% of the murine 22q11.2 del embryos when assessed at embryonic e10.5 (equivalent to human embryonic week 7) (<xref ref-type="bibr" rid="B81">Lindsay and Baldini, 2001</xref>; <xref ref-type="bibr" rid="B62">Karpinski et al., 2014</xref>). However, this penetrance drops dramatically between e12.5-e18.5, such that only 30% of the 22q11.2del pups have CHD at term (<xref ref-type="bibr" rid="B81">Lindsay and Baldini, 2001</xref>). This indicates a regenerative or corrective process in genetically identical embryos, which could be explained by epigenetic modifiers, a possibility that requires further analysis.</p>
</sec>
<sec id="s7">
<title>Independent Chromosomal Deletions in Relation to 22q11.2del</title>
<p>In an analysis of &gt;1400 22q11.2del patients, 1% were found to have secondary mutations at other loci (<xref ref-type="bibr" rid="B101">Michaud et al., 1995</xref>; <xref ref-type="bibr" rid="B93">Mcdonald-Mcginn et al., 2013</xref>; <xref ref-type="bibr" rid="B68">Kruszka et al., 2017</xref>). These secondary mutations, including some affecting the presumed normal allele of chromosome 22q11.2, are resulting in dual diagnoses (<xref ref-type="bibr" rid="B27">Cohen et al., 2018</xref>). A few of the more prominent diagnoses include CHARGE (Coloboma, heart defects, atresia choanae, growth retardation, genital and ear anomalies) syndrome, cystic fibrosis, G6PD deficiency, 17q12 deletion syndrome, and von Willebrand disease (<xref ref-type="bibr" rid="B101">Michaud et al., 1995</xref>; <xref ref-type="bibr" rid="B93">Mcdonald-Mcginn et al., 2013</xref>; <xref ref-type="bibr" rid="B27">Cohen et al., 2018</xref>). Whether these secondary mutations at distinct loci influence the expression of genes on chromosome 22q11.2 has not been assessed. There are also reports of patients with 22q11.2del-like phenotypes due to chromosomal deletions at unrelated loci. Among these are microdeletions on 10p13, 4q34, and 3p12.3 (<xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref>). Terminal deletions on the short arm of chromosome 10 cause 10p syndrome. Described in over 46 patients, the phenotypes are split into two: DiGeorge syndrome 2 (DGS2) (OMIM# 601362) and hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) (OMIM# 146255) (<xref ref-type="bibr" rid="B152">Van Esch et al., 2000</xref>). DGS2 results from haploinsufficiency of the more proximal region of 10p13-10p14. The resulting cardiac anomalies and thymic hypoplasia are coupled to a haploinsufficiency of <italic>BRUNOL3</italic> (<italic>NAPOR, CUGBP2, ETR3</italic>) (<xref ref-type="bibr" rid="B80">Lichtner et al., 2002</xref>). HDR is a separate syndrome involving deletions in the more terminal region of chromosome 10 (10p14-10pter) that result in a hemizygosity of <italic>GATA3</italic> (<xref ref-type="bibr" rid="B84">Lindstrand et al., 2010</xref>). Chromosomal deletions of the terminal end of 4q34 cause chromosome 4q syndrome, with at least one patient reported with clinical phenotypes of 22q11.2del (<xref ref-type="bibr" rid="B30">Cuturilo et al., 2011</xref>; <xref ref-type="bibr" rid="B142">Strehle et al., 2012</xref>). A 371-kb interstitial deletion of 3p12.3 was reported for a male child with a clinical presentation of 22q11.2del (<xref ref-type="bibr" rid="B26">Cirillo et al., 2017</xref>). Two miRNAs, miR-1243 and miR-4273 along with the <italic>Zinc Finger Protein 717</italic> (<italic>ZNF717)</italic> are affected by this deletion, resulting in DiGeorge-like syndrome and renal insufficiency. Given the clinical overlap among these different microdeletions, it is anticipated that several may affect <italic>TBX1</italic> expression and/or modulate histone modifications among cells differentiating within the pharyngeal region.</p>
</sec>
<sec id="s8">
<title>Summary</title>
<p>Rapid advances in our understanding of the molecular mechanisms underpinning the heterogeneous clinical presentations of 22q11.2del are creating exciting new possibilities for earlier diagnosis and better treatment strategies for affected individuals. The introduction of TREC testing as part of newborn screening throughout the US and in other countries has accelerated the time when infants with 22q11.2del are diagnosed, and this will mean in more rapid and appropriate clinical interventions (<xref ref-type="bibr" rid="B35">Dorsey et al., 2017</xref>). Innovations in whole genome sequencing and DNA-based microarrays also make possible an accurate diagnosis of 22q11.2del in the developing fetus using maternal blood sampling (<xref ref-type="bibr" rid="B165">Yatsenko et al., 2015</xref>; <xref ref-type="bibr" rid="B130">Schmid et al., 2017</xref>). These non-invasive prenatal tests are very sensitive and have low false positive discovery rates (<xref ref-type="bibr" rid="B119">Ravi et al., 2018</xref>). Improvements in sequencing limited amounts of fetal DNA from maternal sampling is moving the field to 1<sup>st</sup> trimester screening (<xref ref-type="bibr" rid="B138">Srinivasan et al., 2013</xref>; <xref ref-type="bibr" rid="B54">Helgeson et al., 2015</xref>) (ClinicalTrials.gov Identifier: NCT03375359). This is important because the pharyngeal defects arise during this period. Mitigating the damage to the pharyngeal region in <italic>TBX1</italic>-haploinsufficient embryos at this time point will definitely improve clinical outcomes. In the post-natal period, managing physiological stress should improve vulnerabilities due to miRNA dysregulation, arising from the reduced levels of <italic>DGCR8</italic>. The identification of small drugs able to modulate the consequences of the haploinsufficiency of both <italic>TBX1</italic> and <italic>DGCR8</italic> suggest new strategies for reducing the clinical penetrance and severity of 22q11.2del (<xref ref-type="bibr" rid="B5">Barr et al., 2015</xref>; <xref ref-type="bibr" rid="B42">Fulcoli et al., 2016</xref>). In summary, DNA and RNA sequencing approaches are unveiling new genetic and epigenetic modifiers among the 22q11.2del cohort that have a significant impact on disease penetrance and severity. Identifying and understanding these genetic and epigenetic regulators in an individualized manner for each 22q11.2del patient will direct future care in order to minimize disease severity.</p>
</sec>
<sec id="s9">
<title>Author Contributions</title>
<p>All authors, QD, MM, and NO contributed to the review of the literature, the writing of the manuscript, and the preparation of data in tables and figures.</p>
</sec>
<sec id="s10" sec-type="funding-information">
<title>Funding</title>
<p>Our work was supported, in part, by grants from the National Institutes of Health R01 (R01 AI114523, R21 AI144140 NO), Beecherl funds from the Department of Immunology at UT Southwestern Medical Center (NO), and the Jeffrey Modell Foundation (MM).</p>
</sec>
<sec id="s11">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Drs. M Louise Markert (Duke University) and Robert P. Nelson (Indiana University School of Medicine) for helpful discussions and information. We also thank Dr. Pratibha Bhalla and Ms. Fatma Coskun (UT Southwestern Medical Center) for reviewing the figures in the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alfano</surname><given-names>D.</given-names></name><name><surname>Altomonte</surname><given-names>A.</given-names></name><name><surname>Cortes</surname><given-names>C.</given-names></name><name><surname>Bilio</surname><given-names>M.</given-names></name><name><surname>Kelly</surname><given-names>R. G.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Tbx1 regulates extracellular matrix-cell interactions in the second heart field</article-title>. <source/>Hum. Mol. Genet. <volume>28</volume>, <fpage>2295</fpage>–<lpage>2308</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddz058</pub-id>
<pub-id pub-id-type="pmid">31180501</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alles</surname><given-names>J.</given-names></name><name><surname>Fehlmann</surname><given-names>T.</given-names></name><name><surname>Fischer</surname><given-names>U.</given-names></name><name><surname>Backes</surname><given-names>C.</given-names></name><name><surname>Galata</surname><given-names>V.</given-names></name><name><surname>Minet</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>An estimate of the total number of true human miRNAs</article-title>. <source/>Nucleic Acids Res.
<volume>47</volume>, <fpage>3353</fpage>–<lpage>3364</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz097</pub-id>
<pub-id pub-id-type="pmid">30820533</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Angrand</surname><given-names>P.-O.</given-names></name><name><surname>Vennin</surname><given-names>C.</given-names></name><name><surname>Le Bourhis</surname><given-names>X.</given-names></name><name><surname>Adriaenssens</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of long non-coding RNAs in genome formatting and expression</article-title>. <source/>Front. Genet.
<volume>6</volume>, <elocation-id>165</elocation-id>. <pub-id pub-id-type="doi">10.3389/fgene.2015.00165</pub-id>
<pub-id pub-id-type="pmid">25972893</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baldini</surname><given-names>A.</given-names></name><name><surname>Fulcoli</surname><given-names>F. G.</given-names></name><name><surname>Illingworth</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Tbx1: transcriptional and developmental functions</article-title>. <source/>Curr. Topics Dev. Biol
<volume>122</volume>, <fpage>223</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.08.002</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barr</surname><given-names>I.</given-names></name><name><surname>Weitz</surname><given-names>S. H.</given-names></name><name><surname>Atkin</surname><given-names>T.</given-names></name><name><surname>Hsu</surname><given-names>P.</given-names></name><name><surname>Karayiorgou</surname><given-names>M.</given-names></name><name><surname>Gogos</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cobalt(III) Protoporphyrin activates the DGCR8 protein and can compensate microRNA processing deficiency</article-title>. <source/>Chem. Biol.
<volume>22</volume>, <fpage>793</fpage>–<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2015.05.015</pub-id>
<pub-id pub-id-type="pmid">26091172</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D. P.</given-names></name></person-group> (<year>2009</year>). <article-title>MicroRNAs: target recognition and regulatory functions</article-title>. <source/>Cell
<volume>136</volume>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bassett</surname><given-names>A. S.</given-names></name><name><surname>Chow</surname><given-names>E. W.</given-names></name><name><surname>Husted</surname><given-names>J.</given-names></name><name><surname>Weksberg</surname><given-names>R.</given-names></name><name><surname>Caluseriu</surname><given-names>O.</given-names></name><name><surname>Webb</surname><given-names>G. D.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Clinical features of 78 adults with 22q11 deletion syndrome</article-title>. <source/>Am. J. Med. Genet. A.
<volume>138</volume>, <fpage>307</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30984</pub-id>
<pub-id pub-id-type="pmid">16208694</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bassett</surname><given-names>A. S.</given-names></name><name><surname>Chow</surname><given-names>E. W. C.</given-names></name><name><surname>Husted</surname><given-names>J.</given-names></name><name><surname>Hodgkinson</surname><given-names>K. A.</given-names></name><name><surname>Oechslin</surname><given-names>E.</given-names></name><name><surname>Harris</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Premature death in adults with 22q11.2 deletion syndrome</article-title>. <source/>J. Med. Genet.
<volume>46</volume>, <fpage>324</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.063800</pub-id>
<pub-id pub-id-type="pmid">19246480</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bassett</surname><given-names>A. S.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Devriendt</surname><given-names>K.</given-names></name><name><surname>Digilio</surname><given-names>M. C.</given-names></name><name><surname>Goldenberg</surname><given-names>P.</given-names></name><name><surname>Habel</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Practical guidelines for managing patients with 22q11.2 deletion syndrome</article-title>. <source/>J. Pediatr.
<volume>159</volume>, <fpage>332</fpage>–<lpage>339 e331</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2011.02.039</pub-id>
<pub-id pub-id-type="pmid">21570089</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bastos Maia</surname><given-names>S.</given-names></name><name><surname>Rolland Souza</surname><given-names>A. S.</given-names></name><name><surname>Costa Caminha</surname><given-names>M. F.</given-names></name><name><surname>Lins Da Silva</surname><given-names>S.</given-names></name><name><surname>Callou Cruz</surname><given-names>R.</given-names></name><name><surname>Carvalho Dos Santos</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Vitamin A and pregnancy: a narrative review</article-title>. <source/>Nutrients
<volume>11</volume>. <pub-id pub-id-type="doi">10.3390/nu11030681</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belkaya</surname><given-names>S.</given-names></name><name><surname>Silge</surname><given-names>R. L.</given-names></name><name><surname>Hoover</surname><given-names>A. R.</given-names></name><name><surname>Medeiros</surname><given-names>J. J.</given-names></name><name><surname>Eitson</surname><given-names>J. L.</given-names></name><name><surname>Becker</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Dynamic modulation of thymic microRNAs in response to stress</article-title>. <source/>PloS One
<volume>6</volume>, <elocation-id>e27580</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0027580</pub-id>
<pub-id pub-id-type="pmid">22110677</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belkaya</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>S. E.</given-names></name><name><surname>Eitson</surname><given-names>J. L.</given-names></name><name><surname>De La Morena</surname><given-names>M. T.</given-names></name><name><surname>Forman</surname><given-names>J. A.</given-names></name><name><surname>Van Oers</surname><given-names>N. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1</article-title>. <source/>J. Biol. Chem.
<volume>288</volume>, <fpage>30752</fpage>–<lpage>30762</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.503532</pub-id>
<pub-id pub-id-type="pmid">24014023</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belver</surname><given-names>L.</given-names></name><name><surname>De Yebenes</surname><given-names>V. G.</given-names></name><name><surname>Ramiro</surname><given-names>A. R.</given-names></name></person-group> (<year>2010</year>). <article-title>MicroRNAs prevent the generation of autoreactive antibodies</article-title>. <source/>Immunity
<volume>33</volume>, <fpage>713</fpage>–<lpage>722</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2010.11.010</pub-id>
<pub-id pub-id-type="pmid">21093320</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bertini</surname><given-names>V.</given-names></name><name><surname>Azzarà</surname><given-names>A.</given-names></name><name><surname>Legitimo</surname><given-names>A.</given-names></name><name><surname>Milone</surname><given-names>R.</given-names></name><name><surname>Battini</surname><given-names>R.</given-names></name><name><surname>Consolini</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Deletion extents are not the cause of clinical variability in 22q11.2 deletion syndrome: does the interaction between DGCR8 and miRNA-CNVs play a major role</article-title>? <source/>Front. Genet.
<volume>8</volume>, <elocation-id>47</elocation-id>. <pub-id pub-id-type="doi">10.3389/fgene.2017.00047</pub-id>
<pub-id pub-id-type="pmid">28507561</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bittel</surname><given-names>D. C.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Newkirk</surname><given-names>H.</given-names></name><name><surname>Kibiryeva</surname><given-names>N.</given-names></name><name><surname>Holt</surname><given-names>A.</given-names><suffix>3rd</suffix></name><name><surname>Butler</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH</article-title>. <source/>Cytogenet. Genome Res.
<volume>124</volume>, <fpage>113</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1159/000207515</pub-id>
<pub-id pub-id-type="pmid">19420922</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Botto</surname><given-names>L. D.</given-names></name><name><surname>May</surname><given-names>K.</given-names></name><name><surname>Fernhoff</surname><given-names>P. M.</given-names></name><name><surname>Correa</surname><given-names>A.</given-names></name><name><surname>Coleman</surname><given-names>K.</given-names></name><name><surname>Rasmussen</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population</article-title>. <source/>Pediatrics
<volume>112</volume>, <fpage>101</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1542/peds.112.1.101</pub-id>
<pub-id pub-id-type="pmid">12837874</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brenner</surname><given-names>M. K.</given-names></name><name><surname>Clarke</surname><given-names>S.</given-names></name><name><surname>Mahnke</surname><given-names>D. K.</given-names></name><name><surname>Simpson</surname><given-names>P.</given-names></name><name><surname>Bercovitz</surname><given-names>R. S.</given-names></name><name><surname>Tomita-Mitchell</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery</article-title>. <source/>Pediatr. Res.
<volume>79</volume>, <fpage>318</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2015.216</pub-id>
<pub-id pub-id-type="pmid">26492284</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Browne</surname><given-names>H.</given-names></name><name><surname>Mason</surname><given-names>G.</given-names></name><name><surname>Tang</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Retinoids and pregnancy: an update</article-title>. <source/>Obstetrician Gynaecolog.
<volume>16</volume>, <fpage>7</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1111/tog.12075</pub-id>.</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burnside</surname><given-names>R. D.</given-names></name></person-group> (<year>2015</year>). <article-title>22q11.21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features</article-title>. <source/>Cytogenet. Genome Res.
<volume>0</volume>, <fpage>89</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1159/000438708</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cesana</surname><given-names>M.</given-names></name><name><surname>Cacchiarelli</surname><given-names>D.</given-names></name><name><surname>Legnini</surname><given-names>I.</given-names></name><name><surname>Santini</surname><given-names>T.</given-names></name><name><surname>Sthandier</surname><given-names>O.</given-names></name><name><surname>Chinappi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA</article-title>. <source/>Cell
<volume>147</volume>, <fpage>358</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.09.028</pub-id>
<pub-id pub-id-type="pmid">22000014</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>D.</given-names></name><name><surname>Bernal</surname><given-names>A. J.</given-names></name><name><surname>Schoch</surname><given-names>K.</given-names></name><name><surname>Howard</surname><given-names>T. D.</given-names></name><name><surname>Ip</surname><given-names>E. H.</given-names></name><name><surname>Hooper</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome</article-title>. <source/>Trans. Psychiatry
<volume>2</volume>, <elocation-id>e105</elocation-id>. <pub-id pub-id-type="doi">10.1038/tp.2012.31</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Fulcoli</surname><given-names>F. G.</given-names></name><name><surname>Ferrentino</surname><given-names>R.</given-names></name><name><surname>Martucciello</surname><given-names>S.</given-names></name><name><surname>Illingworth</surname><given-names>E. A.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Transcriptional control in cardiac progenitors: Tbx1 interacts with the BAF chromatin remodeling complex and regulates Wnt5a</article-title>. <source/>PloS Genet.
<volume>8</volume>, <fpage>e1002571</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002571</pub-id>
<pub-id pub-id-type="pmid">22438823</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>E.-G. G.</given-names></name><name><surname>Zhang</surname><given-names>J.-S. S.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>X.-J. J.</given-names></name><name><surname>Hu</surname><given-names>H.-H. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Long non-coding RNA DGCR5 is involved in the regulation of proliferation, migration and invasion of lung cancer by targeting miR-1180</article-title>. <source/>Am. J. Cancer Res.
<volume>7</volume>, <fpage>1463</fpage>–<lpage>1475</lpage>.<pub-id pub-id-type="pmid">28744397</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cipollone</surname><given-names>D.</given-names></name><name><surname>Amati</surname><given-names>F.</given-names></name><name><surname>Carsetti</surname><given-names>R.</given-names></name><name><surname>Placidi</surname><given-names>S.</given-names></name><name><surname>Biancolella</surname><given-names>M.</given-names></name><name><surname>D’amati</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>A multiple retinoic acid antagonist induces conotruncal anomalies, including transposition of the great arteries, in mice</article-title>. <source/>Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol.
<volume>15</volume>, <fpage>194</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.carpath.2006.04.004</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cirera-Salinas</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Bodak</surname><given-names>M.</given-names></name><name><surname>Ngondo</surname><given-names>R. P.</given-names></name><name><surname>Herbert</surname><given-names>K. M.</given-names></name><name><surname>Ciaudo</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Noncanonical function of DGCR8 controls mESC exit from pluripotency</article-title>. <source/>J. Cell Biol.
<volume>216</volume>, <fpage>355</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201606073</pub-id>
<pub-id pub-id-type="pmid">28100686</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cirillo</surname><given-names>E.</given-names></name><name><surname>Giardino</surname><given-names>G.</given-names></name><name><surname>Gallo</surname><given-names>V.</given-names></name><name><surname>Galasso</surname><given-names>G.</given-names></name><name><surname>Romano</surname><given-names>R.</given-names></name><name><surname>D’assante</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>DiGeorge-like syndrome in a child with a 3p12.3 deletion involving MIR4273 gene born to a mother with gestational diabetes mellitus</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>173</volume>, <fpage>1913</fpage>–<lpage>1918</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38242</pub-id>
<pub-id pub-id-type="pmid">28436605</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J. L.</given-names></name><name><surname>Crowley</surname><given-names>T. B.</given-names></name><name><surname>Mcginn</surname><given-names>D. E.</given-names></name><name><surname>Mcdougall</surname><given-names>C.</given-names></name><name><surname>Unolt</surname><given-names>M.</given-names></name><name><surname>Lambert</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>22q and two: 22q11.2 deletion syndrome and coexisting conditions</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>176</volume>, <fpage>2203</fpage>–<lpage>2214</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.40494</pub-id>
<pub-id pub-id-type="pmid">30244528</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Conley</surname><given-names>M. E.</given-names></name><name><surname>Beckwith</surname><given-names>J. B.</given-names></name><name><surname>Mancer</surname><given-names>J. F.</given-names></name><name><surname>Tenckhoff</surname><given-names>L.</given-names></name></person-group> (<year>1979</year>). <article-title>The spectrum of the DiGeorge syndrome</article-title>. <source/>J. Pediatr.
<volume>94</volume>, <fpage>883</fpage>–<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(79)80207-3</pub-id>
<pub-id pub-id-type="pmid">448529</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Consortium</surname><given-names>T.</given-names></name><name><surname>Mlynarski</surname><given-names>E. E.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>D.</given-names></name><name><surname>Sheridan</surname><given-names>M. B.</given-names></name><name><surname>Guo</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome</article-title>. <source/>Hum. Genet.
<volume>135</volume>, <fpage>273</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-015-1623-9</pub-id>
<pub-id pub-id-type="pmid">26742502</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cuturilo</surname><given-names>G.</given-names></name><name><surname>Menten</surname><given-names>B.</given-names></name><name><surname>Krstic</surname><given-names>A.</given-names></name><name><surname>Drakulic</surname><given-names>D.</given-names></name><name><surname>Jovanovic</surname><given-names>I.</given-names></name><name><surname>Parezanovic</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>4q34.1–q35.2 deletion in a boy with phenotype resembling 22q11.2 deletion syndrome</article-title>. <source/>Eur. J. Pediatr.
<volume>170</volume>, <fpage>1465</fpage>–<lpage>1470</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-011-1533-3</pub-id>
<pub-id pub-id-type="pmid">21833498</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De La Morena</surname><given-names>M. T.</given-names></name><name><surname>Eitson</surname><given-names>J. L.</given-names></name><name><surname>Dozmorov</surname><given-names>I. M.</given-names></name><name><surname>Belkaya</surname><given-names>S.</given-names></name><name><surname>Hoover</surname><given-names>A. R.</given-names></name><name><surname>Anguiano</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome</article-title>. <source/>Clin. Immunol.
<volume>147</volume>, <fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2013.01.011</pub-id>
<pub-id pub-id-type="pmid">23454892</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Delihas</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>A family of long intergenic non-coding RNA genes in human chromosomal region 22q11.2 carry a DNA translocation breakpoint/AT-rich sequence</article-title>. <source/>PloS One
<volume>13</volume>, <elocation-id>e0195702</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0195702</pub-id>
<pub-id pub-id-type="pmid">29668722</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dey</surname><given-names>B. K.</given-names></name><name><surname>Pfeifer</surname><given-names>K.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration</article-title>. <source/>Genes Dev.
<volume>28</volume>, <fpage>491</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1101/gad.234419.113</pub-id>
<pub-id pub-id-type="pmid">24532688</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dornemann</surname><given-names>R.</given-names></name><name><surname>Koch</surname><given-names>R.</given-names></name><name><surname>Mollmann</surname><given-names>U.</given-names></name><name><surname>Falkenberg</surname><given-names>M. K.</given-names></name><name><surname>Mollers</surname><given-names>M.</given-names></name><name><surname>Klockenbusch</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Fetal thymus size in pregnant women with diabetic diseases</article-title>. <source/>J. Perinat. Med.
<volume>45</volume>, <fpage>595</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2016-0400</pub-id>
<pub-id pub-id-type="pmid">28195554</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>M. J.</given-names></name><name><surname>Dvorak</surname><given-names>C. C.</given-names></name><name><surname>Cowan</surname><given-names>M. J.</given-names></name><name><surname>Puck</surname><given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening</article-title>. <source/>J. Allergy Clin. Immunol.
<volume>139</volume>, <fpage>733</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.01.005</pub-id>
<pub-id pub-id-type="pmid">28270365</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Du</surname><given-names>Q.</given-names></name><name><surname>Hoover</surname><given-names>A. R.</given-names></name><name><surname>Dozmorov</surname><given-names>I.</given-names></name><name><surname>Raj</surname><given-names>P.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Molina</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>MIR205HG is a long noncoding RNA that regulates growth hormone and prolactin production in the anterior pituitary</article-title>. <source/>Dev. Cell
<volume>49</volume>
<fpage>618</fpage>–<lpage>631</lpage>, e615. <pub-id pub-id-type="doi">10.1016/j.devcel.2019.03.012</pub-id>
<pub-id pub-id-type="pmid">30982661</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupuis-Sandoval</surname><given-names>F.</given-names></name><name><surname>Poirier</surname><given-names>M.</given-names></name><name><surname>Scott</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>The emerging landscape of small nucleolar RNAs in cell biology</article-title>. <source/>Wiley Interdiscip. Rev.: RNA
<volume>6</volume>, <fpage>381</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.1284</pub-id>
<pub-id pub-id-type="pmid">25879954</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Earls</surname><given-names>L.</given-names></name><name><surname>Bayazitov</surname><given-names>I.</given-names></name><name><surname>Fricke</surname><given-names>R.</given-names></name><name><surname>Berry</surname><given-names>R.</given-names></name><name><surname>Illingworth</surname><given-names>E.</given-names></name><name><surname>Mittleman</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome</article-title>. <source/>J. Neurosci. Off. J. Soc. Neurosci.
<volume>30</volume>, <fpage>15843</fpage>–<lpage>15855</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1425-10.2010</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Earls</surname><given-names>L. R.</given-names></name><name><surname>Fricke</surname><given-names>R. G.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Berry</surname><given-names>R. B.</given-names></name><name><surname>Baldwin</surname><given-names>L. T.</given-names></name><name><surname>Zakharenko</surname><given-names>S. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Age-dependent MicroRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia</article-title>. <source/>J. Neurosci. Off. J. Soc. Neurosci.
<volume>32</volume>, <fpage>14132</fpage>–<lpage>14144</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1312-12.2012</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ensenauer</surname><given-names>R. E.</given-names></name><name><surname>Adeyinka</surname><given-names>A.</given-names></name><name><surname>Flynn</surname><given-names>H. C.</given-names></name><name><surname>Michels</surname><given-names>V. V.</given-names></name><name><surname>Lindor</surname><given-names>N. M.</given-names></name><name><surname>Dawson</surname><given-names>D. B.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients</article-title>. <source/>Am. J. Hum. Genet.
<volume>73</volume>, <fpage>1027</fpage>–<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1086/378818</pub-id>
<pub-id pub-id-type="pmid">14526392</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fulcoli</surname><given-names>F. G.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Scambler</surname><given-names>P. J.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Tbx1 regulates the BMP-Smad1 pathway in a transcription independent manner</article-title>. <source/>PloS One
<volume>4</volume>, <elocation-id>e6049</elocation-id>–e6049. <pub-id pub-id-type="doi">10.1371/journal.pone.0006049</pub-id>
<pub-id pub-id-type="pmid">19557177</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fulcoli</surname><given-names>F.</given-names></name><name><surname>Franzese</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Angelini</surname><given-names>C.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Rebalancing gene haploinsufficiency <italic>in vivo</italic> by targeting chromatin</article-title>. <source/>Nat. Commun.
<volume>7</volume>, <fpage>11688</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11688</pub-id>
<pub-id pub-id-type="pmid">27256596</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fung</surname><given-names>W. L.</given-names></name><name><surname>Butcher</surname><given-names>N. J.</given-names></name><name><surname>Costain</surname><given-names>G.</given-names></name><name><surname>Andrade</surname><given-names>D. M.</given-names></name><name><surname>Boot</surname><given-names>E.</given-names></name><name><surname>Chow</surname><given-names>E. W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Practical guidelines for managing adults with 22q11.2 deletion syndrome</article-title>. <source/>Genet. Med.
<volume>17</volume>, <fpage>599</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2014.175</pub-id>
<pub-id pub-id-type="pmid">25569435</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Moreno</surname><given-names>M.</given-names></name><name><surname>Eliason</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2015</year>a). <article-title>TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>2330</fpage>–<lpage>2348</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu750</pub-id>
<pub-id pub-id-type="pmid">25556186</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Higaki</surname><given-names>T.</given-names></name><name><surname>Eguchi-Ishimae</surname><given-names>M.</given-names></name><name><surname>Iwabuki</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Yamamoto</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>b). <article-title>DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects</article-title>. <source/>Hum. Genome Variation
<volume>2</volume>, <fpage>15004</fpage>. <pub-id pub-id-type="doi">10.1038/hgv.2015.4</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>S. R.</given-names></name><name><surname>Mishina</surname><given-names>Y.</given-names></name><name><surname>Manley</surname><given-names>N. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis</article-title>. <source/>Dev. Biol.
<volume>339</volume>, <fpage>141</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.12.026</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grati</surname><given-names>F. R.</given-names></name><name><surname>Molina Gomes</surname><given-names>D.</given-names></name><name><surname>Ferreira</surname><given-names>J. C. P. B.</given-names></name><name><surname>Dupont</surname><given-names>C.</given-names></name><name><surname>Alesi</surname><given-names>V.</given-names></name><name><surname>Gouas</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies</article-title>. <source/>Prenatal Diagnosis
<volume>35</volume>, <fpage>801</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1002/pd.4613</pub-id>
<pub-id pub-id-type="pmid">25962607</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Groot</surname><given-names>A. C.</given-names></name><name><surname>Hierck</surname><given-names>B. P.</given-names></name><name><surname>Molin</surname><given-names>D. G. M.</given-names></name><name><surname>Boot</surname><given-names>M. J.</given-names></name><name><surname>Poelmann</surname><given-names>R. E.</given-names></name></person-group> (<year>2004</year>). <article-title>A chicken model for DGCR6 as a modifier gene in the DiGeorge critical region</article-title>. <source/>Pediatr. Res.
<volume>56</volume>, <fpage>440</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000136151.50127.1C</pub-id>
<pub-id pub-id-type="pmid">15333760</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grosshans</surname><given-names>H.</given-names></name><name><surname>Filipowicz</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Molecular biology: the expanding world of small RNAs</article-title>. <source/>Nature
<volume>451</volume>, <fpage>414</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1038/451414a</pub-id>
<pub-id pub-id-type="pmid">18216846</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guna</surname><given-names>A.</given-names></name><name><surname>Butcher</surname><given-names>N. J.</given-names></name><name><surname>Bassett</surname><given-names>A. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms</article-title>. <source/>J. Neurodev. Disord.
<volume>7</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s11689-015-9113-x</pub-id>
<pub-id pub-id-type="pmid">25972975</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Chung</surname><given-names>J. H.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Kates</surname><given-names>W. R.</given-names></name><name><surname>Hawuła</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Histone modifier genes alter conotruncal heart phenotypes in 22q11.2 deletion syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>97</volume>, <fpage>869</fpage>–<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.10.013</pub-id>
<pub-id pub-id-type="pmid">26608785</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haertle</surname><given-names>L.</given-names></name><name><surname>El Hajj</surname><given-names>N.</given-names></name><name><surname>Dittrich</surname><given-names>M.</given-names></name><name><surname>Müller</surname><given-names>T.</given-names></name><name><surname>Nanda</surname><given-names>I.</given-names></name><name><surname>Lehnen</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Epigenetic signatures of gestational diabetes mellitus on cord blood methylation</article-title>. <source/>Clin. Epigenet.
<volume>9</volume>, <fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/s13148-017-0329-3</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>Z.-J.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Wen</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.-F.</given-names></name><name><surname>Liu</surname><given-names>Y.-J.</given-names></name></person-group> (<year>2018</year>). <article-title>miR-1306–3p targets FBXL5 to promote metastasis of hepatocellular carcinoma through suppressing snail degradation</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>504</volume>, <fpage>820</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.09.059</pub-id>
<pub-id pub-id-type="pmid">30219228</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Helgeson</surname><given-names>J.</given-names></name><name><surname>Wardrop</surname><given-names>J.</given-names></name><name><surname>Boomer</surname><given-names>T.</given-names></name><name><surname>Almasri</surname><given-names>E.</given-names></name><name><surname>Paxton</surname><given-names>W. B.</given-names></name><name><surname>Saldivar</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing</article-title>. <source/>Prenatal Diagnosis
<volume>35</volume>, <fpage>999</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1002/pd.4640</pub-id>
<pub-id pub-id-type="pmid">26088833</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hwang</surname><given-names>V. J.</given-names></name><name><surname>Maar</surname><given-names>D.</given-names></name><name><surname>Regan</surname><given-names>J.</given-names></name><name><surname>Angkustsiri</surname><given-names>K.</given-names></name><name><surname>Simon</surname><given-names>T. J.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR</article-title>. <source/>BMC Med. Genet.
<volume>15</volume>, <fpage>106</fpage>. <pub-id pub-id-type="doi">10.1186/s12881-014-0106-5</pub-id>
<pub-id pub-id-type="pmid">25312060</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>D.</given-names></name><name><surname>Bursch</surname><given-names>M.</given-names></name><name><surname>Lajiness-O’neill</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Potential role of Cortisol in social and memory impairments in individuals with 22q11.2 deletion syndrome</article-title>. <source/>J. Pediatr. Genet.
<volume>5</volume>, <fpage>150</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1584549</pub-id>
<pub-id pub-id-type="pmid">27617156</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>W. E.</given-names></name><name><surname>Rossi</surname><given-names>S. W.</given-names></name><name><surname>Parnell</surname><given-names>S. M.</given-names></name><name><surname>Jenkinson</surname><given-names>E. J.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches</article-title>. <source/>Blood
<volume>109</volume>, <fpage>954</fpage>–<lpage>960</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-05-023143</pub-id>
<pub-id pub-id-type="pmid">17008543</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jerome</surname><given-names>L. A.</given-names></name><name><surname>Papaioannou</surname><given-names>V. E.</given-names></name></person-group> (<year>2001</year>). <article-title>DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1</article-title>. <source/>Nat. Genet.
<volume>27</volume>, <fpage>286</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/85845</pub-id>
<pub-id pub-id-type="pmid">11242110</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>Farlie</surname><given-names>P. G.</given-names></name><name><surname>Minichiello</surname><given-names>J.</given-names></name><name><surname>Newgreen</surname><given-names>D. F.</given-names></name></person-group> (<year>1999</year>). <article-title>Detection of an appropriate kinase activity in branchial arches I and II that coincides with peak expression of the treacher collins syndrome gene product, treacle</article-title>. <source/>Hum. Mol. Genet.
<volume>8</volume>, <fpage>2239</fpage>–<lpage>2245</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/8.12.2239</pub-id>
<pub-id pub-id-type="pmid">10545604</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karayiorgou</surname><given-names>M.</given-names></name><name><surname>Morris</surname><given-names>M. A.</given-names></name><name><surname>Morrow</surname><given-names>B.</given-names></name><name><surname>Shprintzen</surname><given-names>R. J.</given-names></name><name><surname>Goldberg</surname><given-names>R.</given-names></name><name><surname>Borrow</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>92</volume>, <fpage>7612</fpage>–<lpage>7616</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.17.7612</pub-id>
<pub-id pub-id-type="pmid">7644464</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karayiorgou</surname><given-names>M.</given-names></name><name><surname>Simon</surname><given-names>T. J.</given-names></name><name><surname>Gogos</surname><given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia</article-title>. <source/>Nat. Rev. Neurosci.
<volume>11</volume>, <fpage>402</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2841</pub-id>
<pub-id pub-id-type="pmid">20485365</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karpinski</surname><given-names>B. A.</given-names></name><name><surname>Maynard</surname><given-names>T. M.</given-names></name><name><surname>Fralish</surname><given-names>M. S.</given-names></name><name><surname>Nuwayhid</surname><given-names>S.</given-names></name><name><surname>Zohn</surname><given-names>I. E.</given-names></name><name><surname>Moody</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome</article-title>. <source/>Dis. Models Mech.
<volume>7</volume>, <fpage>245</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.012484</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keniry</surname><given-names>A.</given-names></name><name><surname>Oxley</surname><given-names>D.</given-names></name><name><surname>Monnier</surname><given-names>P.</given-names></name><name><surname>Kyba</surname><given-names>M.</given-names></name><name><surname>Dandolo</surname><given-names>L.</given-names></name><name><surname>Smits</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r</article-title>. <source/>Nat. Cell Biol.
<volume>14</volume>, <fpage>659</fpage>–<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2521</pub-id>
<pub-id pub-id-type="pmid">22684254</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. O.</given-names></name><name><surname>Song</surname><given-names>D. W.</given-names></name><name><surname>Kwon</surname><given-names>E. J.</given-names></name><name><surname>Hong</surname><given-names>S.-E.</given-names></name><name><surname>Song</surname><given-names>H. K.</given-names></name><name><surname>Min</surname><given-names>C. K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>miR-185 plays an anti-hypertrophic role in the heart <italic>via</italic> multiple targets in the calcium-signaling pathways</article-title>. <source/>PloS One
<volume>10</volume>, <fpage>e0122509</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0122509</pub-id>
<pub-id pub-id-type="pmid">25767890</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kimber</surname><given-names>W. L.</given-names></name><name><surname>Hsieh</surname><given-names>P.</given-names></name><name><surname>Hirotsune</surname><given-names>S.</given-names></name><name><surname>Yuva-Paylor</surname><given-names>L.</given-names></name><name><surname>Sutherland</surname><given-names>H. F.</given-names></name><name><surname>Chen</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse</article-title>. <source/>Hum. Mol. Genet.
<volume>8</volume>, <fpage>2229</fpage>–<lpage>2237</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/8.12.2229</pub-id>
<pub-id pub-id-type="pmid">10545603</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kobrynski</surname><given-names>L. J.</given-names></name><name><surname>Sullivan</surname><given-names>K. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes</article-title>. <source/>Lancet
<volume>370</volume>, <fpage>1443</fpage>–<lpage>1452</lpage>. 10.1016/S0140-6736(07)61601-8<pub-id pub-id-type="pmid">17950858</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krol</surname><given-names>J.</given-names></name><name><surname>Loedige</surname><given-names>I.</given-names></name><name><surname>Filipowicz</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>The widespread regulation of microRNA biogenesis, function and decay</article-title>. <source/>Nat. Rev. Genet.
<volume>11</volume>. <pub-id pub-id-type="doi">10.1038/nrg2843</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kruszka</surname><given-names>P.</given-names></name><name><surname>Addissie</surname><given-names>Y. A.</given-names></name><name><surname>Mcginn</surname><given-names>D. E.</given-names></name><name><surname>Porras</surname><given-names>A. R.</given-names></name><name><surname>Biggs</surname><given-names>E.</given-names></name><name><surname>Share</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>22q11.2 deletion syndrome in diverse populations</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>173</volume>, <fpage>879</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38199</pub-id>
<pub-id pub-id-type="pmid">28328118</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kucera</surname><given-names>J.</given-names></name></person-group> (<year>1971</year>). <article-title>Rate and type of congenital anomalies among offspring of diabetic women</article-title>. <source/>J. Reprod. Med.
<volume>7</volume>, <fpage>73</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">5095696</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwan</surname><given-names>A.</given-names></name><name><surname>Abraham</surname><given-names>R. S.</given-names></name><name><surname>Currier</surname><given-names>R.</given-names></name><name><surname>Brower</surname><given-names>A.</given-names></name><name><surname>Andruszewski</surname><given-names>K.</given-names></name><name><surname>Abbott</surname><given-names>J. K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States newborn screening for severe combined immunodeficiency newborn screening for severe combined immunodeficiency</article-title>. <source/>JAMA
<volume>312</volume>, <fpage>729</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.9132</pub-id>
<pub-id pub-id-type="pmid">25138334</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lambrechts</surname><given-names>D.</given-names></name><name><surname>Devriendt</surname><given-names>K.</given-names></name><name><surname>Driscoll</surname><given-names>D. A.</given-names></name><name><surname>Goldmuntz</surname><given-names>E.</given-names></name><name><surname>Gewillig</surname><given-names>M.</given-names></name><name><surname>Vlietinck</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Low expression <italic>VEGF</italic> haplotype increases the risk for tetralogy of Fallot: a family based association study</article-title>. <source/>J. Med. Genet.
<volume>42</volume>, <fpage>519</fpage>–<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.026443</pub-id>
<pub-id pub-id-type="pmid">15937089</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lammer</surname><given-names>E. J.</given-names></name><name><surname>Chen</surname><given-names>D. T.</given-names></name><name><surname>Hoar</surname><given-names>R. M.</given-names></name><name><surname>Agnish</surname><given-names>N. D.</given-names></name><name><surname>Benke</surname><given-names>P. J.</given-names></name><name><surname>Braun</surname><given-names>J. T.</given-names></name><etal></etal></person-group> (<year>1985</year>). <article-title>Retinoic acid embryopathy</article-title>. <source/>New Engl. J. Med.
<volume>313</volume>, <fpage>837</fpage>–<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198510033131401</pub-id>
<pub-id pub-id-type="pmid">3162101</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landthaler</surname><given-names>M.</given-names></name><name><surname>Yalcin</surname><given-names>A.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis</article-title>. <source/>Curr. Biol.
<volume>14</volume>, <fpage>2162</fpage>–<lpage>2167</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.11.001</pub-id>
<pub-id pub-id-type="pmid">15589161</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>León</surname><given-names>L. E.</given-names></name><name><surname>Benavides</surname><given-names>F.</given-names></name><name><surname>Espinoza</surname><given-names>K.</given-names></name><name><surname>Vial</surname><given-names>C.</given-names></name><name><surname>Alvarez</surname><given-names>P.</given-names></name><name><surname>Palomares</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Partial microduplication in the histone acetyltransferase complex member KANSL1 is associated with congenital heart defects in 22q11.2 microdeletion syndrome patients</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>1795</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-01896-w</pub-id>
<pub-id pub-id-type="pmid">28496102</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Ahn</surname><given-names>C.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Yim</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>The nuclear RNase III Drosha initiates microRNA processing</article-title>. <source/>Nature
<volume>425</volume>. <pub-id pub-id-type="doi">10.1038/nature01957</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kopp</surname><given-names>F.</given-names></name><name><surname>Chang</surname><given-names>T.-C.</given-names></name><name><surname>Sataluri</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Sivakumar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins</article-title>. <source/>Cell
<volume>164</volume>, <fpage>69</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.12.017</pub-id>
<pub-id pub-id-type="pmid">26724866</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>L. M. Y.</given-names></name><name><surname>Leung</surname><given-names>M. B. W.</given-names></name><name><surname>Kwok</surname><given-names>R. C. Y.</given-names></name><name><surname>Leung</surname><given-names>Y. C.</given-names></name><name><surname>Wang</surname><given-names>C. C.</given-names></name><name><surname>Mccaffery</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Perturbation of retinoid homeostasis increases malformation risk in embryos exposed to pregestational diabetes</article-title>. <source/>Diabetes
<volume>66</volume>, <fpage>1041</fpage>–<lpage>1051</lpage>. <pub-id pub-id-type="doi">10.2337/db15-1570</pub-id>
<pub-id pub-id-type="pmid">28087565</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leung</surname><given-names>A. K.</given-names></name><name><surname>Sharp</surname><given-names>P. A.</given-names></name></person-group> (<year>2010</year>). <article-title>MicroRNA functions in stress responses</article-title>. <source/>Mol. Cell
<volume>40</volume>, <fpage>205</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.027</pub-id>
<pub-id pub-id-type="pmid">20965416</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>B. P.</given-names></name><name><surname>Burge</surname><given-names>C. B.</given-names></name><name><surname>Bartel</surname><given-names>D. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. <source/>Cell
<volume>120</volume>, <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.035</pub-id>
<pub-id pub-id-type="pmid">15652477</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtner</surname><given-names>P.</given-names></name><name><surname>Attié-Bitach</surname><given-names>T.</given-names></name><name><surname>Schuffenhauer</surname><given-names>S.</given-names></name><name><surname>Henwood</surname><given-names>J.</given-names></name><name><surname>Bouvagnet</surname><given-names>P.</given-names></name><name><surname>Scambler</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p</article-title>. <source/>J. Mol. Med.
<volume>80</volume>, <fpage>431</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-002-0331-9</pub-id>
<pub-id pub-id-type="pmid">12110949</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>E. A.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region</article-title>. <source/>Hum. Mol. Genet.
<volume>10</volume>, <fpage>997</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.9.997</pub-id>
<pub-id pub-id-type="pmid">11309372</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>E. A.</given-names></name><name><surname>Botta</surname><given-names>A.</given-names></name><name><surname>Jurecic</surname><given-names>V.</given-names></name><name><surname>Carattini-Rivera</surname><given-names>S.</given-names></name><name><surname>Cheah</surname><given-names>Y. C.</given-names></name><name><surname>Rosenblatt</surname><given-names>H. M.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Congenital heart disease in mice deficient for the DiGeorge syndrome region</article-title>. <source/>Nature
<volume>401</volume>, <fpage>379</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1038/43900</pub-id>
<pub-id pub-id-type="pmid">10517636</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>E. A.</given-names></name><name><surname>Vitelli</surname><given-names>F.</given-names></name><name><surname>Su</surname><given-names>H.</given-names></name><name><surname>Morishima</surname><given-names>M.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Pramparo</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice</article-title>. <source/>Nature
<volume>410</volume>, <fpage>97</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/35065105</pub-id>
<pub-id pub-id-type="pmid">11242049</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lindstrand</surname><given-names>A.</given-names></name><name><surname>Malmgren</surname><given-names>H.</given-names></name><name><surname>Verri</surname><given-names>A.</given-names></name><name><surname>Benetti</surname><given-names>E.</given-names></name><name><surname>Eriksson</surname><given-names>M.</given-names></name><name><surname>Nordgren</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Molecular and clinical characterization of patients with overlapping 10p deletions</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>152A</volume>, <fpage>1233</fpage>–<lpage>1243</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33366</pub-id>
<pub-id pub-id-type="pmid">20425828</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lipson</surname><given-names>A. H.</given-names></name><name><surname>Collins</surname><given-names>F.</given-names></name><name><surname>Webster</surname><given-names>W. S.</given-names></name></person-group> (<year>1993</year>). <article-title>Multiple congenital defects associated with maternal use of topical tretinoin</article-title>. <source/>Lancet
<volume>341</volume>, <fpage>1352</fpage>–<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1016/0140-6736(93)90868-h</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Selever</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Lu</surname><given-names>M.-F.</given-names></name><name><surname>Moses</surname><given-names>K. A.</given-names></name><name><surname>Schwartz</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>101</volume>, <fpage>4489</fpage>–<lpage>4494</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308466101</pub-id>
<pub-id pub-id-type="pmid">15070745</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.-H.</given-names></name><name><surname>Tsai</surname><given-names>Z.</given-names></name><name><surname>Tsai</surname><given-names>H.-K.</given-names></name></person-group> (<year>2017</year>). <article-title>Comparative genomic analyses highlight the contribution of pseudogenized protein-coding genes to human lincRNAs</article-title>. <source/>BMC Genomics
<volume>18</volume>, <fpage>786</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-017-4156-x</pub-id>
<pub-id pub-id-type="pmid">29037146</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lodish</surname><given-names>H. F.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>C. Z.</given-names></name></person-group> (<year>2008</year>). <article-title>Micromanagement of the immune system by microRNAs</article-title>. <source/>Nat. Rev. Immunol.
<volume>8</volume>, <fpage>120</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1038/nri2252</pub-id>
<pub-id pub-id-type="pmid">18204468</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcovecchio</surname><given-names>G.</given-names></name><name><surname>Bortolomai</surname><given-names>I.</given-names></name><name><surname>Ferrua</surname><given-names>F.</given-names></name><name><surname>Fontana</surname><given-names>E.</given-names></name><name><surname>Imberti</surname><given-names>L.</given-names></name><name><surname>Conforti</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Thymic Epithelium abnormalities in DiGeorge and down syndrome patients contribute to dysregulation in T cell development</article-title>. <source/>Front. Immunol.
<volume>10</volume>, <elocation-id>447</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00447</pub-id><pub-id pub-id-type="pmid">30949166</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Markert</surname><given-names>M. L.</given-names></name><name><surname>Devlin</surname><given-names>B. H.</given-names></name><name><surname>Alexieff</surname><given-names>M. J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mccarthy</surname><given-names>E. A.</given-names></name><name><surname>Gupton</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants</article-title>. <source/>Blood
<volume>109</volume>, <fpage>4539</fpage>–<lpage>4547</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-10-048652</pub-id>
<pub-id pub-id-type="pmid">17284531</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Kirschner</surname><given-names>R.</given-names></name><name><surname>Goldmuntz</surname><given-names>E.</given-names></name><name><surname>Sullivan</surname><given-names>K.</given-names></name><name><surname>Eicher</surname><given-names>P.</given-names></name><name><surname>Gerdes</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>The Philadelphia story: the 22q11.2 deletion: report on 250 patients</article-title>. <source/>Genet. Couns.
<volume>10</volume>, <fpage>11</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">10191425</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Reilly</surname><given-names>A.</given-names></name><name><surname>Wallgren-Pettersson</surname><given-names>C.</given-names></name><name><surname>Hoyme</surname><given-names>H. E.</given-names></name><name><surname>Yang</surname><given-names>S. P.</given-names></name><name><surname>Adam</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)</article-title>. <source/>Am. J. Med. Genet. A.
<volume>140</volume>, <fpage>906</fpage>–<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31199</pub-id>
<pub-id pub-id-type="pmid">16532473</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Fahiminiya</surname><given-names>S.</given-names></name><name><surname>Revil</surname><given-names>T.</given-names></name><name><surname>Nowakowska</surname><given-names>B. A.</given-names></name><name><surname>Suhl</surname><given-names>J.</given-names></name><name><surname>Bailey</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS</article-title>. <source/>J. Med. Genet.
<volume>50</volume>, <fpage>80</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101320</pub-id>
<pub-id pub-id-type="pmid">23231787</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Sullivan</surname><given-names>K. E.</given-names></name><name><surname>Marino</surname><given-names>B.</given-names></name><name><surname>Philip</surname><given-names>N.</given-names></name><name><surname>Swillen</surname><given-names>A.</given-names></name><name><surname>Vorstman</surname><given-names>J. A. S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>22q11.2 deletion syndrome</article-title>. <source/>Nat. Rev. Dis. Primers
<volume>15071</volume>. <pub-id pub-id-type="doi">10.1038/nrdp.2015.71</pub-id>
</mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcmahon</surname><given-names>M.</given-names></name><name><surname>Contreras</surname><given-names>A.</given-names></name><name><surname>Ruggero</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease</article-title>. <source/>Wiley Interdiscip. Rev.: RNA
<volume>6</volume>, <fpage>173</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.1266</pub-id>
<pub-id pub-id-type="pmid">25363811</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meechan</surname><given-names>D. W.</given-names></name><name><surname>Maynard</surname><given-names>T. M.</given-names></name><name><surname>Tucker</surname><given-names>E. S.</given-names></name><name><surname>Fernandez</surname><given-names>A.</given-names></name><name><surname>Karpinski</surname><given-names>B. A.</given-names></name><name><surname>Rothblat</surname><given-names>L. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Modeling a model: mouse genetics, 22q11.2 deletion syndrome, and disorders of cortical circuit development</article-title>. <source/>Prog. Neurobiol.
<volume>130</volume>, <fpage>1</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.03.004</pub-id>
<pub-id pub-id-type="pmid">25866365</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mencia</surname><given-names>A.</given-names></name><name><surname>Modamio-Hoybjor</surname><given-names>S.</given-names></name><name><surname>Redshaw</surname><given-names>N.</given-names></name><name><surname>Morin</surname><given-names>M.</given-names></name><name><surname>Mayo-Merino</surname><given-names>F.</given-names></name><name><surname>Olavarrieta</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss</article-title>. <source/>Nat. Genet.
<volume>41</volume>, <fpage>609</fpage>–<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1038/ng.355</pub-id>
<pub-id pub-id-type="pmid">19363479</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendell</surname><given-names>J. T.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>2012</year>). <article-title>MicroRNAs in stress signaling and human disease</article-title>. <source/>Cell
<volume>148</volume>, <fpage>1172</fpage>–<lpage>1187</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.005</pub-id>
<pub-id pub-id-type="pmid">22424228</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Costain</surname><given-names>G.</given-names></name><name><surname>Butcher</surname><given-names>N. J.</given-names></name><name><surname>Warnica</surname><given-names>W.</given-names></name><name><surname>Ogura</surname><given-names>L.</given-names></name><name><surname>Alfred</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome</article-title>. <source/>Front. Neurol.
<volume>5</volume>, <elocation-id>238</elocation-id>. <pub-id pub-id-type="doi">10.3389/fneur.2014.00238</pub-id>
<pub-id pub-id-type="pmid">25484875</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merscher</surname><given-names>S.</given-names></name><name><surname>Funke</surname><given-names>B.</given-names></name><name><surname>Epstein</surname><given-names>J. A.</given-names></name><name><surname>Heyer</surname><given-names>J.</given-names></name><name><surname>Puech</surname><given-names>A.</given-names></name><name><surname>Lu</surname><given-names>M. M.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome</article-title>. <source/>Cell
<volume>104</volume>, <fpage>619</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00247-1</pub-id>
<pub-id pub-id-type="pmid">11239417</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Michaud</surname><given-names>D.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Budarf</surname><given-names>M. L.</given-names></name><name><surname>Zackai</surname><given-names>E. H.</given-names></name><name><surname>Driscoll</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/Velo-cardio-facial chromosomal region in 22q11.2</article-title>. <source/>Hum. Mol. Genet.
<volume>4</volume>, <fpage>763</fpage>–<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/4.4.763</pub-id>
<pub-id pub-id-type="pmid">7633430</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mills</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Malformations in infants of diabetic mothers</article-title>. <source/>Birth Defects Res. Part A.: Clin. Mol. Teratol.
<volume>88</volume>, <fpage>769</fpage>–<lpage>778</lpage>.<pub-id pub-id-type="pmid">20973049</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mlynarski</surname><given-names>E. E.</given-names></name><name><surname>Sheridan</surname><given-names>M. B.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Racedo</surname><given-names>S. E.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>96</volume>, <fpage>753</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.03.007</pub-id>
<pub-id pub-id-type="pmid">25892112</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mokate</surname><given-names>T.</given-names></name><name><surname>Leask</surname><given-names>K.</given-names></name><name><surname>Mehta</surname><given-names>S.</given-names></name><name><surname>Sharif</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Saxena</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Non-mosaic trisomy 22: a report of 2 cases</article-title>. <source/>Prenatal Diagnosis
<volume>26</volume>, <fpage>962</fpage>–<lpage>965</lpage>. <pub-id pub-id-type="doi">10.1002/pd.1537</pub-id>
<pub-id pub-id-type="pmid">16906599</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moreno-Igoa</surname><given-names>M.</given-names></name><name><surname>Hernández-Charro</surname><given-names>B.</given-names></name><name><surname>Bengoa-Alonso</surname><given-names>A.</given-names></name><name><surname>Pérez-Juana-Del-Casal</surname><given-names>A.</given-names></name><name><surname>Romero-Ibarra</surname><given-names>C.</given-names></name><name><surname>Nieva-Echebarria</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome</article-title>. <source/>BMC Med. Genet.
<volume>16</volume>, <fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/s12881-015-0211-0</pub-id>
<pub-id pub-id-type="pmid">26293599</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrow</surname><given-names>B. E.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D. M.</given-names></name><name><surname>Emanuel</surname><given-names>B. S.</given-names></name><name><surname>Vermeesch</surname><given-names>J. R.</given-names></name><name><surname>Scambler</surname><given-names>P. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Molecular genetics of 22q11.2 deletion syndrome</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>176</volume>, <fpage>2070</fpage>–<lpage>2081</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.40504</pub-id>
<pub-id pub-id-type="pmid">30380194</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morsheimer</surname><given-names>M.</given-names></name><name><surname>Whitehorn</surname><given-names>T. F.</given-names></name><name><surname>Heimall</surname><given-names>J.</given-names></name><name><surname>Sullivan</surname><given-names>K. E.</given-names></name></person-group> (<year>2017</year>). <article-title>The immune deficiency of chromosome 22q11.2 deletion syndrome</article-title>. <source/>Am. J. Med. Genet. Part A. <pub-id pub-id-type="doi">10.1002/ajmg.a.38319</pub-id>
</mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Munk</surname><given-names>R.</given-names></name><name><surname>Martindale</surname><given-names>J. L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>J.-H.</given-names></name><name><surname>Grammatikakis</surname><given-names>I.</given-names></name><name><surname>Di Germanio</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Loss of miR-451a enhances SPARC production during myogenesis</article-title>. <source/>PloS One
<volume>14</volume>, <elocation-id>e0214301</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0214301</pub-id>
<pub-id pub-id-type="pmid">30925184</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nesan</surname><given-names>D.</given-names></name><name><surname>Vijayan</surname><given-names>M. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Embryo exposure to elevated cortisol level leads to cardiac performance dysfunction in zebrafish</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>363</volume>, <fpage>85</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2012.07.010</pub-id>
<pub-id pub-id-type="pmid">22842336</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niederreither</surname><given-names>K.</given-names></name><name><surname>Vermot</surname><given-names>J.</given-names></name><name><surname>Le Roux</surname><given-names>I.</given-names></name><name><surname>Schuhbaur</surname><given-names>B.</given-names></name><name><surname>Chambon</surname><given-names>P.</given-names></name><name><surname>Dolle</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system</article-title>. <source/>Development
<volume>130</volume>, <fpage>2525</fpage>–<lpage>2534</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00463</pub-id>
<pub-id pub-id-type="pmid">12702665</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nowakowski</surname><given-names>T. J.</given-names></name><name><surname>Rani</surname><given-names>N.</given-names></name><name><surname>Golkaram</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>H. R.</given-names></name><name><surname>Alvarado</surname><given-names>B.</given-names></name><name><surname>Huch</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Regulation of cell-type-specific transcriptomes by microRNA networks during human brain development</article-title>. <source/>Nat. Neurosci.
<volume>21</volume>, <fpage>1784</fpage>–<lpage>1792</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0265-3</pub-id>
<pub-id pub-id-type="pmid">30455455</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Óskarsdóttir</surname><given-names>S.</given-names></name><name><surname>Persson</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>B. O.</given-names></name><name><surname>Fasth</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Presenting phenotype in 100 children with the 22q11 deletion syndrome</article-title>. <source/>Eur. J. Pediatr.
<volume>164</volume>, <fpage>146</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-004-1577-8</pub-id>
<pub-id pub-id-type="pmid">15565286</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>R.</given-names></name><name><surname>Shafiullah</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Effect of maternal diabetes and ethanol interactions on embryo development in the mouse</article-title>. <source/>Mol. Cell. Biochem.
<volume>261</volume>, <fpage>43</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1023/b:mcbi.0000028736.00532.1e</pub-id>
<pub-id pub-id-type="pmid">15362484</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paganini</surname><given-names>I.</given-names></name><name><surname>Sestini</surname><given-names>R.</given-names></name><name><surname>Capone</surname><given-names>G. L.</given-names></name><name><surname>Putignano</surname><given-names>A. L.</given-names></name><name><surname>Contini</surname><given-names>E.</given-names></name><name><surname>Giotti</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency</article-title>. <source/>Clin. Genet.
<volume>92</volume>, <fpage>664</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1111/cge.13085</pub-id>
<pub-id pub-id-type="pmid">28657137</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pohl</surname><given-names>E.</given-names></name><name><surname>Aykut</surname><given-names>A.</given-names></name><name><surname>Beleggia</surname><given-names>F.</given-names></name><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Durmaz</surname><given-names>B.</given-names></name><name><surname>Keupp</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndrome</article-title>. <source/>Hum. Genet.
<volume>132</volume>, <fpage>1311</fpage>–<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1337-9</pub-id>
<pub-id pub-id-type="pmid">23851939</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Puech</surname><given-names>A.</given-names></name><name><surname>Saint-Jore</surname><given-names>B.</given-names></name><name><surname>Merscher</surname><given-names>S.</given-names></name><name><surname>Russell</surname><given-names>R. G.</given-names></name><name><surname>Cherif</surname><given-names>D.</given-names></name><name><surname>Sirotkin</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region</article-title>. <source/>Proc. Natl. Acad. Sci.
<volume>97</volume>, <fpage>10090</fpage>–<lpage>10095</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.18.10090</pub-id>
<pub-id pub-id-type="pmid">10963672</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quinn</surname><given-names>J. J.</given-names></name><name><surname>Chang</surname><given-names>H. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Unique features of long non-coding RNA biogenesis and function</article-title>. <source/>Nat. Rev. Genet.
<volume>17</volume>, <fpage>47</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2015.10</pub-id>
<pub-id pub-id-type="pmid">26666209</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramírez-Rosas</surname><given-names>E.</given-names></name><name><surname>Velázquez</surname><given-names>P. N.</given-names></name><name><surname>Verdugo-Díaz</surname><given-names>L.</given-names></name><name><surname>Pérez-Armendáriz</surname><given-names>E. M.</given-names></name><name><surname>Juárez-Oropeza</surname><given-names>M. A.</given-names></name><name><surname>Paredes-Carbajal</surname><given-names>M. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Subchronic stress effects on vascular reactivity in C57BL/6 strain mice</article-title>. <source/>Physiol. Behav.
<volume>204</volume>, <fpage>283</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2019.03.007</pub-id>
<pub-id pub-id-type="pmid">30862478</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravi</surname><given-names>H.</given-names></name><name><surname>Mcneill</surname><given-names>G.</given-names></name><name><surname>Goel</surname><given-names>S.</given-names></name><name><surname>Meltzer</surname><given-names>S. D.</given-names></name><name><surname>Hunkapiller</surname><given-names>N.</given-names></name><name><surname>Ryan</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples</article-title>. <source/>PloS One
<volume>13</volume>, <fpage>e0193476</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0193476</pub-id>
<pub-id pub-id-type="pmid">29474437</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reeh</surname><given-names>K. A. G.</given-names></name><name><surname>Cardenas</surname><given-names>K. T.</given-names></name><name><surname>Bain</surname><given-names>V. E.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Laurent</surname><given-names>M.</given-names></name><name><surname>Manley</surname><given-names>N. R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis</article-title>. <source/>Development
<volume>141</volume>, <fpage>2950</fpage>–<lpage>2958</lpage>. <pub-id pub-id-type="doi">10.1242/dev.111641</pub-id>
<pub-id pub-id-type="pmid">25053428</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Repetto</surname><given-names>G. M.</given-names></name><name><surname>Guzmán</surname><given-names>M. L.</given-names></name><name><surname>Delgado</surname><given-names>I.</given-names></name><name><surname>Loyola</surname><given-names>H.</given-names></name><name><surname>Palomares</surname><given-names>M.</given-names></name><name><surname>Lay-Son</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study</article-title>. <source/>BMJ Open
<volume>4</volume>. <pub-id pub-id-type="doi">10.1136/bmjopen-2014-005041</pub-id>
</mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richarte</surname><given-names>A. M.</given-names></name><name><surname>Mead</surname><given-names>H. B.</given-names></name><name><surname>Tallquist</surname><given-names>M. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Cooperation between the PDGF receptors in cardiac neural crest cell migration</article-title>. <source/>Dev. Biol.
<volume>306</volume>, <fpage>785</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2007.04.023</pub-id>
<pub-id pub-id-type="pmid">17499702</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roberts</surname><given-names>C.</given-names></name><name><surname>Ivins</surname><given-names>S. M.</given-names></name><name><surname>James</surname><given-names>C. T.</given-names></name><name><surname>Scambler</surname><given-names>P. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Retinoic acid down-regulates Tbx1 expression <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title>. <source/>Dev. Dynamics: Off. Publ. Am. Assoc. Anatomists
<volume>232</volume>, <fpage>928</fpage>–<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20268</pub-id>
</mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ronchetti</surname><given-names>D.</given-names></name><name><surname>Agnelli</surname><given-names>L.</given-names></name><name><surname>Pietrelli</surname><given-names>A.</given-names></name><name><surname>Todoerti</surname><given-names>K.</given-names></name><name><surname>Manzoni</surname><given-names>M.</given-names></name><name><surname>Taiana</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma</article-title>. <source/>Sci. Rep.
<volume>8</volume>, <fpage>6557</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-24701-8</pub-id>
<pub-id pub-id-type="pmid">29700321</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryckebusch</surname><given-names>L.</given-names></name><name><surname>Bertrand</surname><given-names>N.</given-names></name><name><surname>Mesbah</surname><given-names>K.</given-names></name><name><surname>Bajolle</surname><given-names>F.</given-names></name><name><surname>Niederreither</surname><given-names>K.</given-names></name><name><surname>Kelly</surname><given-names>R. G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome</article-title>. <source/>Circ. Res.
<volume>106</volume>, <fpage>686</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.205732</pub-id>
<pub-id pub-id-type="pmid">20110535</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sachar</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>K. E.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>Protoporphyrin IX: the Good, the Bad, and the Ugly</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>356</volume>, <fpage>267</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.115.228130</pub-id>
<pub-id pub-id-type="pmid">26588930</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sacks</surname><given-names>D. A.</given-names></name><name><surname>Hadden</surname><given-names>D. R.</given-names></name><name><surname>Maresh</surname><given-names>M.</given-names></name><name><surname>Deerochanawong</surname><given-names>C.</given-names></name><name><surname>Dyer</surname><given-names>A. R.</given-names></name><name><surname>Metzger</surname><given-names>B. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel–recommended criteria</article-title>. <source/>Hyperglycemia Adverse Pregnancy Outcome (HAPO) Study
<volume>35</volume>, <fpage>526</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.2337/dc11-1641</pub-id>
</mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saitta</surname><given-names>S. C.</given-names></name><name><surname>Mcgrath</surname><given-names>J. M.</given-names></name><name><surname>Mensch</surname><given-names>H.</given-names></name><name><surname>Shaikh</surname><given-names>T. H.</given-names></name><name><surname>Zackai</surname><given-names>E. H.</given-names></name><name><surname>Emanuel</surname><given-names>B. S.</given-names></name></person-group> (<year>1999</year>). <article-title>A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects</article-title>. <source/>Am. J. Hum. Genet.
<volume>65</volume>, <fpage>562</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1086/302514</pub-id>
<pub-id pub-id-type="pmid">10417299</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salmena</surname><given-names>L.</given-names></name><name><surname>Poliseno</surname><given-names>L.</given-names></name><name><surname>Tay</surname><given-names>Y.</given-names></name><name><surname>Kats</surname><given-names>L.</given-names></name><name><surname>Pandolfi</surname><given-names>P. P.</given-names></name></person-group> (<year>2011</year>). <article-title>A ceRNA hypothesis: the Rosetta stone of a hidden RNA language</article-title>? <source/>Cell
<volume>146</volume>, <fpage>353</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.07.014</pub-id>
<pub-id pub-id-type="pmid">21802130</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmid</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Bogard</surname><given-names>P. E.</given-names></name><name><surname>Bevilacqua</surname><given-names>E.</given-names></name><name><surname>Hacker</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Prenatal screening for 22q11.2 deletion using a targeted microarray-based cell-free DNA test</article-title>. <source/>Fetal Diagnosis Ther. <pub-id pub-id-type="doi">10.1159/000484317</pub-id>
</mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schofield</surname><given-names>C.</given-names></name><name><surname>Hsu</surname><given-names>R.</given-names></name><name><surname>Barker</surname><given-names>A.</given-names></name><name><surname>Gertz</surname><given-names>C.</given-names></name><name><surname>Blelloch</surname><given-names>R.</given-names></name><name><surname>Ullian</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex</article-title>. <source/>Neural Dev.
<volume>6</volume>, <fpage>11</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8104-6-11</pub-id>
<pub-id pub-id-type="pmid">21466685</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sellier</surname><given-names>C.</given-names></name><name><surname>Hwang</surname><given-names>V. J.</given-names></name><name><surname>Dandekar</surname><given-names>R.</given-names></name><name><surname>Durbin-Johnson</surname><given-names>B.</given-names></name><name><surname>Charlet-Berguerand</surname><given-names>N.</given-names></name><name><surname>Ander</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome</article-title>. <source/>PloS One
<volume>9</volume>, <elocation-id>e103884</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103884</pub-id>
<pub-id pub-id-type="pmid">25084529</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shaikh</surname><given-names>T. H.</given-names></name><name><surname>Kurahashi</surname><given-names>H.</given-names></name><name><surname>Saitta</surname><given-names>S. C.</given-names></name><name><surname>O’hare</surname><given-names>A. M.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Roe</surname><given-names>B. A.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis</article-title>. <source/>Hum. Mol. Genet.
<volume>9</volume>, <fpage>489</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.4.489</pub-id>
<pub-id pub-id-type="pmid">10699172</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shaikh</surname><given-names>T. H.</given-names></name><name><surname>Kurahashi</surname><given-names>H.</given-names></name><name><surname>Emanuel</surname><given-names>B. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review</article-title>. <source/>Genet. In Med. Off. J. Am. Coll. Med. Genet.
<volume>3</volume>, <fpage>6</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1097/00125817-200101000-00003</pub-id>
</mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shaikh</surname><given-names>T. H.</given-names></name><name><surname>O’connor</surname><given-names>R. J.</given-names></name><name><surname>Pierpont</surname><given-names>M. E.</given-names></name><name><surname>Mcgrath</surname><given-names>J.</given-names></name><name><surname>Hacker</surname><given-names>A. M.</given-names></name><name><surname>Nimmakayalu</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms</article-title>. <source/>Genome Res.
<volume>17</volume>, <fpage>482</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1101/gr.5986507</pub-id>
<pub-id pub-id-type="pmid">17351135</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simpson</surname><given-names>I. A.</given-names></name><name><surname>Dwyer</surname><given-names>D.</given-names></name><name><surname>Malide</surname><given-names>D.</given-names></name><name><surname>Moley</surname><given-names>K. H.</given-names></name><name><surname>Travis</surname><given-names>A.</given-names></name><name><surname>Vannucci</surname><given-names>S. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The facilitative glucose transporter GLUT3: 20 years of distinction</article-title>. <source/>Am. J. Physiol. Endocrinol. Metab.
<volume>295</volume>, <fpage>E242</fpage>–<lpage>E253</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.90388.2008</pub-id>
<pub-id pub-id-type="pmid">18577699</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>Tallquist</surname><given-names>M. D.</given-names></name></person-group> (<year>2010</year>). <article-title>PDGF function in diverse neural crest cell populations</article-title>. <source/>Cell Adhesion Migration
<volume>4</volume>, <fpage>561</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.4161/cam.4.4.12829</pub-id>
<pub-id pub-id-type="pmid">20657170</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>A.</given-names></name><name><surname>Bianchi</surname><given-names>D. W.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Sehnert</surname><given-names>A. J.</given-names></name><name><surname>Rava</surname><given-names>R. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Noninvasive detection of fetal subchromosome abnormalities <italic>via</italic> Deep Sequencing of Maternal Plasma</article-title>. <source/>Am. J. Hum. Genet.
<volume>92</volume>, <fpage>167</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.006</pub-id>
<pub-id pub-id-type="pmid">23313373</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stalmans</surname><given-names>I.</given-names></name><name><surname>Lambrechts</surname><given-names>D.</given-names></name><name><surname>Smet</surname><given-names>F.</given-names></name><name><surname>Jansen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Maity</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>VEGF: a modifier of the del22q11 (DiGeorge) syndrome</article-title>? <source/>Nat. Med.
<volume>9</volume>, <fpage>173</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1038/nm819</pub-id>
<pub-id pub-id-type="pmid">12539040</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stark</surname><given-names>K. L.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Bagchi</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>W. S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Hsu</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model</article-title>. <source/>Nat. Genet.
<volume>40</volume>, <fpage>751</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1038/ng.138</pub-id>
<pub-id pub-id-type="pmid">18469815</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stoller</surname><given-names>J. Z.</given-names></name><name><surname>Epstein</surname><given-names>J. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation</article-title>. <source/>Hum. Mol. Genet.
<volume>14</volume>, <fpage>885</fpage>–<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi081</pub-id>
<pub-id pub-id-type="pmid">15703190</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strehle</surname><given-names>E.-M.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Donkervoort</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>T.-J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genotype–phenotype analysis of 4q deletion syndrome: proposal of a critical region</article-title>. <source/>Am. J. Med. Genet. Part A.
<volume>158A</volume>, <fpage>2139</fpage>–<lpage>2151</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35502</pub-id>
<pub-id pub-id-type="pmid">22847869</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sui</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.-H.</given-names></name><name><surname>Zhang</surname><given-names>Y.-Q.</given-names></name><name><surname>Li</surname><given-names>C.-Y.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>W.-Z.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Integrated analysis of long non-coding RNA-associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma</article-title>. <source/>Int. J. Oncol.
<volume>49</volume>, <fpage>2023</fpage>–<lpage>2036</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2016.3716</pub-id>
<pub-id pub-id-type="pmid">27826625</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>K. E.</given-names></name></person-group> (<year>2004</year>). <article-title>The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome</article-title>. <source/>Curr. Opin. In Allergy Clin. Immunol.
<volume>4</volume>, <fpage>505</fpage>–<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1097/00130832-200412000-00006</pub-id>
<pub-id pub-id-type="pmid">15640691</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>K. E.</given-names></name></person-group> (<year>2019</year>). <article-title>Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome</article-title>. <source/>Immunolog. Rev.
<volume>287</volume>, <fpage>186</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12701</pub-id>
</mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma</article-title>. <source/>Mol. Genet. Genomic Med.
<volume>6</volume>, <fpage>1001</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.473</pub-id>
<pub-id pub-id-type="pmid">30209892</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taddei</surname><given-names>I.</given-names></name><name><surname>Morishima</surname><given-names>M.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Lindsay</surname><given-names>E. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>98</volume>, <fpage>11428</fpage>–<lpage>11431</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.201127298</pub-id>
<pub-id pub-id-type="pmid">11562466</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tallquist</surname><given-names>M. D.</given-names></name><name><surname>Soriano</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Cell autonomous requirement for PDGFRα in populations of cranial and cardiac neural crest cells</article-title>. <source/>Development
<volume>130</volume>, <fpage>507</fpage>–<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00241</pub-id>
<pub-id pub-id-type="pmid">12490557</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Tai</surname><given-names>W. C.-S.</given-names></name><name><surname>Xiong</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma <italic>via</italic> activation of NF-κB signaling pathway</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>22328</fpage>. <pub-id pub-id-type="doi">10.1038/srep22328</pub-id>
<pub-id pub-id-type="pmid">26928365</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tham</surname><given-names>E.</given-names></name><name><surname>Lindstrand</surname><given-names>A.</given-names></name><name><surname>Santani</surname><given-names>A.</given-names></name><name><surname>Malmgren</surname><given-names>H.</given-names></name><name><surname>Nesbitt</surname><given-names>A.</given-names></name><name><surname>Dubbs</surname><given-names>H. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features</article-title>. <source/>Am. J. Hum. Genet.
<volume>96</volume>, <fpage>507</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.01.016</pub-id>
<pub-id pub-id-type="pmid">25728777</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Der Spek</surname><given-names>J.</given-names></name><name><surname>Groenwold</surname><given-names>R. H. H.</given-names></name><name><surname>Van Der Burg</surname><given-names>M.</given-names></name><name><surname>Van Montfrans</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>TREC based newborn screening for severe combined immunodeficiency disease: a systematic review</article-title>. <source/>J. Clin. Immunol.
<volume>35</volume>, <fpage>416</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-015-0152-6</pub-id>
<pub-id pub-id-type="pmid">25893636</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Esch</surname><given-names>H.</given-names></name><name><surname>Groenen</surname><given-names>P.</given-names></name><name><surname>Nesbit</surname><given-names>M. A.</given-names></name><name><surname>Schuffenhauer</surname><given-names>S.</given-names></name><name><surname>Lichtner</surname><given-names>P.</given-names></name><name><surname>Vanderlinden</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>GATA3 haplo-insufficiency causes human HDR syndrome</article-title>. <source/>Nature
<volume>406</volume>, <fpage>419</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1038/35019088</pub-id>
<pub-id pub-id-type="pmid">10935639</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vermot</surname><given-names>J.</given-names></name><name><surname>Niederreither</surname><given-names>K.</given-names></name><name><surname>Garnier</surname><given-names>J. M.</given-names></name><name><surname>Chambon</surname><given-names>P.</given-names></name><name><surname>Dolle</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>100</volume>, <fpage>1763</fpage>–<lpage>1768</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0437920100</pub-id>
<pub-id pub-id-type="pmid">12563036</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vitelli</surname><given-names>F.</given-names></name><name><surname>Taddei</surname><given-names>I.</given-names></name><name><surname>Morishima</surname><given-names>M.</given-names></name><name><surname>Meyers</surname><given-names>E. N.</given-names></name><name><surname>Lindsay</surname><given-names>E. A.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>A genetic link between Tbx1 and fibroblast growth factor signaling</article-title>. <source/>Development
<volume>129</volume>, <fpage>4605</fpage>–<lpage>4611</lpage>.<pub-id pub-id-type="pmid">12223416</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Voss</surname><given-names>A. K.</given-names></name><name><surname>Vanyai</surname><given-names>H. K.</given-names></name><name><surname>Collin</surname><given-names>C.</given-names></name><name><surname>Dixon</surname><given-names>M. P.</given-names></name><name><surname>Mclennan</surname><given-names>T. J.</given-names></name><name><surname>Sheikh</surname><given-names>B. N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>MOZ regulates the Tbx1 Locus, and Moz mutation partially phenocopies DiGeorge syndrome</article-title>. <source/>Dev. Cell
<volume>23</volume>, <fpage>652</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.07.010</pub-id>
<pub-id pub-id-type="pmid">22921202</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wapner</surname><given-names>R. J.</given-names></name><name><surname>Martin</surname><given-names>C. L.</given-names></name><name><surname>Levy</surname><given-names>B.</given-names></name><name><surname>Ballif</surname><given-names>B. C.</given-names></name><name><surname>Eng</surname><given-names>C. M.</given-names></name><name><surname>Zachary</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Chromosomal microarray versus karyotyping for prenatal diagnosis</article-title>. <source/>New Engl. J. Med.
<volume>367</volume>, <fpage>2175</fpage>–<lpage>2184</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1203382</pub-id>
<pub-id pub-id-type="pmid">23215555</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiao</surname><given-names>C.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>MicroRNA control in the immune system: basic principles</article-title>. <source/>Cell
<volume>136</volume>, <fpage>26</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.12.027</pub-id>
<pub-id pub-id-type="pmid">19135886</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Morishima</surname><given-names>M.</given-names></name><name><surname>Wylie</surname><given-names>J. N.</given-names></name><name><surname>Schwartz</surname><given-names>R. J.</given-names></name><name><surname>Bruneau</surname><given-names>B. G.</given-names></name><name><surname>Lindsay</surname><given-names>E. A.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract</article-title>. <source/>Development
<volume>131</volume>, <fpage>3217</fpage>–<lpage>3227</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01174</pub-id>
<pub-id pub-id-type="pmid">15175244</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Hsu</surname><given-names>P.-K.</given-names></name><name><surname>Stark</surname><given-names>K.</given-names></name><name><surname>Karayiorgou</surname><given-names>M.</given-names></name><name><surname>Gogos</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion</article-title>. <source/>Cell
<volume>152</volume>, <fpage>262</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.11.052</pub-id>
<pub-id pub-id-type="pmid">23332760</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Zou</surname><given-names>C.</given-names></name><name><surname>Gong</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1</article-title>. <source/>J. Cell. Physiol.
<volume>234</volume>, <fpage>11999</fpage>–<lpage>12010</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27861</pub-id>
<pub-id pub-id-type="pmid">30515803</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yagi</surname><given-names>H.</given-names></name><name><surname>Furutani</surname><given-names>Y.</given-names></name><name><surname>Hamada</surname><given-names>H.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Asakawa</surname><given-names>S.</given-names></name><name><surname>Minoshima</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Role of TBX1 in human del22q11.2 syndrome</article-title>. <source/>Lancet
<volume>362</volume>, <fpage>1366</fpage>–<lpage>1373</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(03)14632-6</pub-id>
<pub-id pub-id-type="pmid">14585638</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Froberg</surname><given-names>J. E.</given-names></name><name><surname>Lee</surname><given-names>J. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Long noncoding RNAs: fresh perspectives into the RNA world</article-title>. <source/>Trends Biochem. Sci.
<volume>39</volume>, <fpage>35</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2013.10.002</pub-id>
<pub-id pub-id-type="pmid">24290031</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>SnoRNAs are involved in the progression of ulcerative colitis and colorectal cancer</article-title>. <source/>Digestive Liver Dis.
<volume>49</volume>, <fpage>545</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/j.dld.2016.12.029</pub-id>
</mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>Q.</given-names></name><name><surname>Pan</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>miR-1306 mediates the feedback regulation of the TGF-β/SMAD signaling pathway in Granulosa cells</article-title>. <source/>Cells
<volume>8</volume>, <fpage>298</fpage>. <pub-id pub-id-type="doi">10.3390/cells8040298</pub-id>
</mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yatsenko</surname><given-names>S. A.</given-names></name><name><surname>Peters</surname><given-names>D.</given-names></name><name><surname>Saller</surname><given-names>D.</given-names></name><name><surname>Chu</surname><given-names>T.</given-names></name><name><surname>Clemens</surname><given-names>M.</given-names></name><name><surname>Rajkovic</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Maternal cell free DNA based screening for fetal microdeletion and the importance of careful diagnostic follow up</article-title>. <source/>Genet. Med. Off. J. Am. Coll. Med. Genet.
<volume>17</volume>, <fpage>836</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2014.197</pub-id>
</mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>R.</given-names></name><name><surname>Pasolli</surname><given-names>H. A.</given-names></name><name><surname>Landthaler</surname><given-names>M.</given-names></name><name><surname>Hafner</surname><given-names>M.</given-names></name><name><surname>Ojo</surname><given-names>T.</given-names></name><name><surname>Sheridan</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>DGCR8-dependent microRNA biogenesis is essential for skin development</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>106</volume>, <fpage>498</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810766105</pub-id>
<pub-id pub-id-type="pmid">19114655</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zemble</surname><given-names>R.</given-names></name><name><surname>Luning Prak</surname><given-names>E.</given-names></name><name><surname>Mcdonald</surname><given-names>K.</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D.</given-names></name><name><surname>Zackai</surname><given-names>E.</given-names></name><name><surname>Sullivan</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)</article-title>. <source/>Clin. Immunol.
<volume>136</volume>, <fpage>409</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2010.04.011</pub-id>
<pub-id pub-id-type="pmid">20472505</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Baldini</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>In vivo response to high-resolution variation of Tbx1 mRNA dosage</article-title>. <source/>Hum. Mol. Genet.
<volume>17</volume>, <fpage>150</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm291</pub-id>
<pub-id pub-id-type="pmid">17916582</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>D.</given-names></name><name><surname>Jian</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>G. G.</given-names></name><name><surname>Lai</surname><given-names>P. B. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Cancer specific long noncoding RNAs show differential expression patterns and competing endogenous RNA potential in Hepatocellular carcinoma</article-title>. <source/>PloS One
<volume>10</volume>, <fpage>e0141042</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0141042</pub-id>
<pub-id pub-id-type="pmid">26492393</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>MicroRNA-649 promotes HSV-1 replication by directly targeting MALT1</article-title>. <source/>J. Med. Virol.
<volume>89</volume>, <fpage>1069</fpage>–<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.24728</pub-id>
<pub-id pub-id-type="pmid">27813118</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Zhong</surname><given-names>T.</given-names></name><name><surname>Mueller</surname><given-names>M.</given-names></name><name><surname>Men</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase</article-title>. <source/>Nat. Commun.
<volume>6</volume>, <fpage>10221</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms10221</pub-id>
<pub-id pub-id-type="pmid">26687445</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zinkstok</surname><given-names>J. R.</given-names></name><name><surname>Boot</surname><given-names>E.</given-names></name><name><surname>Bassett</surname><given-names>A. S.</given-names></name><name><surname>Hiroi</surname><given-names>N.</given-names></name><name><surname>Butcher</surname><given-names>N. J.</given-names></name><name><surname>Vingerhoets</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Neurobiological perspective of 22q11.2 deletion syndrome</article-title>. <source/>Lancet Psychiatry. <pub-id pub-id-type="doi">10.1016/S2215-0366(19)30076-8</pub-id>
</mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zweier</surname><given-names>C.</given-names></name><name><surname>Sticht</surname><given-names>H.</given-names></name><name><surname>Aydin-Yaylagül</surname><given-names>I.</given-names></name><name><surname>Campbell</surname><given-names>C. E.</given-names></name><name><surname>Rauch</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions</article-title>. <source/>Am. J. Hum. Genet.
<volume>80</volume>, <fpage>510</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1086/511993</pub-id>
<pub-id pub-id-type="pmid">17273972</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>